Statutory Instruments
CONSUMER PROTECTION
Made
17th August 2004
Laid before Parliament
19th August 2004
Coming into force
for the purpose of regulations 7(2)(c) and 7(9)(b)
11th March 2005
for all other purposes
11th September 2004
Whereas the Secretary of State has, in accordance with section 11(5) of the Consumer Protection Act 1987(1), consulted such organisations as appear to her to be representative of interests substantially affected by these Regulations, such other persons as she considers appropriate and the Health and Safety Commission;
And whereas the Secretary of State is a Minister designated (2) for the purposes of section 2 of the European Communities Act 1972(3) in relation to measures for safety and consumer protection as respects cosmetic products and any provisions concerning the composition, labelling, marketing, classification or description of cosmetic products and in relation to indication of origin on imported goods;
Now, therefore, the Secretary of State in exercise of the powers conferred on her by sections 11, 28 and 30 of the 1987 Act and by section 2(2) of the 1972 Act, hereby makes the following Regulations—
1.—(1) These Regulations may be cited as the Cosmetic Products (Safety) Regulations 2004 and shall come into force on 11th September 2004 other than the provisions set out in paragraph (2) below.
(2) The following provisions of these Regulations shall come into force on 11th March 2005—
(a)regulation 7(2)(c); and
(b)regulation 7(9)(b).
(3) Schedules 3,4 and 6 to these Regulations shall have effect until 24th March 2005 with the insertion of the entries referred to in Part 1 of Schedule 1 to these Regulations as they appear in the Cosmetic Products (Safety) Regulations 2003(4) in place of the corresponding entries in the Schedules to these Regulations and thereafter these entries shall have effect as they appear in the Schedules to these Regulations.
(4) The entries referred to in Part 2 of Schedule 1 to these Regulations shall not form part of Schedules 3, 4 and 6 to these Regulations until 24th March 2005.
Commencement Information
I1Reg. 1 in force at 11.9.2004, see reg. 1(1)
2. The Cosmetic Products (Safety) Regulations 2003 are hereby revoked.
Commencement Information
I2Reg. 2 in force at 11.9.2004, see reg. 1(1)
3.—(1) In these Regulations—
“agent” means an agent established within the Community appointed by a manufacturer of a cosmetic product to act on his behalf in relation to these Regulations;
“alternative method” means a testing method which is listed in Schedule 12 to these regulations;
“approved supply list” shall have the same meaning as in regulation 2(1) of the CHIP Regulations;
“the CHIP Regulations” means in Great Britain the Chemicals (Hazard Information and Packaging for Supply) Regulations 2002 and in Northern Ireland the Chemicals (Hazard Information and Packaging for Supply) Regulations (Northern Ireland) 2002 ;
“common ingredients nomenclature” means the labelling nomenclature designated in the inventory of ingredients employed in cosmetic products, drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC(5), as amended or substituted from time to time;
“the Community” means the European Community and other States in the European Economic Area;
“the Confidentiality Directive” means Commission Directive 95/17/EC(6);
“the 1987 Act” means the Consumer Protection Act 1987;
“cosmetic ingredient” means any chemical substance or preparation of synthetic or natural origin, except for perfume and aromatic compositions, used in the composition of a cosmetic product;
“cosmetic product” means any substance or preparation intended to be placed in contact with any part of the external surfaces of the human body (that is to say, the epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, keeping them in good condition or correcting body odours except where such cleaning, perfuming, protecting, changing, keeping or correcting is wholly for the purpose of treating or preventing disease;
“cosmetic product intended to come into contact with the mucous membranes” means a cosmetic product intended to be applied in the vicinity of the eyes, on the lips, in the oral cavity or to the external genital organs, and does not include any cosmetic product which is intended to come into only brief contact with the skin;
“the Directive” means Council Directive 76/768/EEC(7) as amended by the Community instruments set out in Schedule 2;
“EEA Agreement” means the Agreement on the European Economic area signed at Oporto on 2nd May 1992 as amended from time to time;
“finished cosmetic product” means the cosmetic product in its final formulation as placed on the market and made available to the final consumer, or its prototype;
“market research experiment” means any activity conducted for the purpose of ascertaining the opinion of persons of—
any cosmetic product;
anything in, on or with which the cosmetic product is supplied;
the appearance or any other characteristic of the cosmetic product or any such thing; or
the name or description under which the cosmetic product is supplied;
but a cosmetic product is not the subject of a market research experiment unless—
any person to whom a cosmetic product is supplied in the course of the experiment is informed, at or before the time at which it is supplied to him, that it is supplied for the purpose of a market research experiment; and
no consideration in money or money’s worth is given by such a person for the cosmetic product or any other cosmetic product supplied to him for comparison;
“Member State” means a State which is a Contracting Party to the EEA Agreement;
“preservative” means a substance which is added to a cosmetic product for the primary purpose of inhibiting the development of micro-organisms in that product;
“prototype” means a first model or design that has not been produced in batches and from which the finished cosmetic product is copied or finally developed;
“supply” includes offering to supply, agreeing to supply, exposing for supply and possessing for supply, and cognate expressions shall be construed accordingly; and
“UV filter” means a substance which is added to a sunscreen cosmetic product for the primary purpose of filtering ultra violet rays for the purpose of protecting the epidermis of the user from harmful effects of such ultra violet rays.
(2) Unless the contrary intention appears, references in these Regulations to a numbered regulation or Schedule are references to the regulation or Schedule so numbered in these Regulations.
Commencement Information
I3Reg. 3 in force at 11.9.2004, see reg. 1(1)
4.—(1) Subject to paragraph (2) below, no person shall supply any cosmetic product which is liable to cause damage to human health when it is applied under—
(a)normal conditions of use; or
(b)conditions of use which are reasonably foreseeable taking into account all the circumstances, including the cosmetic product’s presentation, labelling, any instructions for its use and disposal and any other information or indication provided by the manufacturer, his agent or the person who supplies the cosmetic product on the first occasion that it is supplied in the Community.
(2) Paragraph (1) above shall apply only to the supply by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, by that other person.
(3) The provision of any instructions, information or indication referred to in sub-paragraph (b) of paragraph (1) above shall not exempt any person from the obligation to comply with any other provisions of these Regulations which are applicable to him.
Commencement Information
I4Reg. 4 in force at 11.9.2004, see reg. 1(1)
5.—(1) The following provisions of this regulation are without prejudice to regulation 4 and are subject to regulation 6.
(2) No person shall supply a cosmetic product which contains—
(a)any substance listed in column 2 of Part I of Schedule 3, provided that no account shall be taken of any such substance which is present only as a trace which could not reasonably have been removed during or after manufacture;
(b)any substance listed in column 2 of Part II of Schedule 3 which is used as a fragrance ingredient in relation to a cosmetic product, provided that no account shall be taken of any such substance which is present only as a trace which could not reasonably have been removed during or after manufacture;
(c)any substance listed in column 2 of Schedule 4, unless the requirements in column 3, 4, 5 and (in the case of Part II) 7 of that Schedule in relation to that substance are satisfied;
(d)any colouring agent listed in columns 1 and 2 of Schedule 5 with the exception of a cosmetic product containing a colouring agent intended solely to colour hair unless—
(i)the requirements in columns 3 and 4 of Part I of that Schedule in relation to that colouring agent are satisfied; or
(ii)the requirements in columns 3 and 4 of Part II of that Schedule in relation to that colouring agent are satisfied and the cosmetic product in question was supplied on or before the date specified in column 5 of that Part;
(e)any colouring agent which is not listed in Schedule 5 with the exception of a cosmetic product containing a colouring agent intended solely to colour hair;
(f)any preservative listed in column 2 of Schedule 6 unless—
(i)the requirements in columns 3, 4 and 5 of Part I of that Schedule in relation to that preservative are satisfied; or
(ii)the requirements in columns 3, 4 and 5 of Part II of that Schedule in relation to that preservative are satisfied and the cosmetic product in question is supplied on or before the date specified in column 7 of that Part;
(g)any preservative which is not listed in Schedule 6;
(h)any preservative listed in column 2 of Part II of Schedule 6 after the date specified in column 7 of that Part;
(i)any UV filter listed in column 2 of Schedule 7 unless—
(i)the requirements in columns 3 and 4 of Part I of that Schedule in relation to that UV filter are satisfied; or
(ii)the requirements in columns 3 and 4 of Part II of that Schedule in relation to that UV filter are satisfied and the cosmetic product in question is supplied on or before the date specified in column 6 of that Part; or
(j)any UV filter which is not listed in Schedule 7.
(3) Subject to paragraphs (4) to (6) below, no person shall supply a cosmetic product which contains any of the substances designated as a specified risk material in Annex V to Regulation (EC) No. 999/2001 of the European Parliament and of the Council(8), or any ingredient derived from any of those substances.
(4) For the purposes of paragraph (3) above, no account shall be taken of any substance referred to in that paragraph which is present in the cosmetic product only as a trace which could not reasonably have been removed during or after manufacture.
(5) Paragraph (3) above shall not prohibit the supply of a cosmetic product which contains any tallow derivative so long as the relevant method set out in Schedule 8 was used in the manufacture of that derivative and the manufacturer of the derivative has certified that that method was used in its manufacture.
(6) Paragraph (3) above shall not prohibit the supply of any cosmetic product which contains any substance or ingredient referred to in that paragraph but which was manufactured before 1st April 1998.
(7) Subject to paragraph (8) below, no person shall supply a cosmetic product where the final formulation has been tested on animals in order that the cosmetic product might satisfy any requirements of these Regulations or the Directive using a method other than an alternative method where—
(a)an alternative method is listed in column 4 of Part 1 or 2 of Schedule 12 to these Regulations; and
(b)the final formulation is tested after the date given in column 5 of Part 1 or 2 of Schedule 12.
(8) No person shall supply a cosmetic product where the final formulation has been tested on animals in order that the cosmetic product might satisfy any requirements of these Regulations or the Directive using a method other than an alternative method after—
(a)11th March 2013 in relation to tests concerning repeated dose toxicity, reproductive toxicity and toxicokinetics; or
(b)11th March 2009 in relation to all other tests.
(9) Subject to paragraph (10) below, no person shall supply a cosmetic product which contains any ingredients or combination of ingredients which have been tested on animals in order that the cosmetic product, ingredient or combination of ingredients might satisfy any requirements of these Regulations or the Directive using a method other than an alternative method where—
(a)an alternative method is listed in column 4 of Part 1 or 2 of Schedule 12 to these Regulations; and
(b)the ingredient or combination of ingredients is tested after the date given in column 5 of Part 1 or 2 of Schedule 12.
(10) No person shall supply a cosmetic product which contains any ingredients or combination of ingredients which have been tested on animals in order that the cosmetic product might satisfy any requirements of these Regulations or the Directive using a method other than an alternative method after—
(a)11th March 2013 in relation to tests concerning repeated dose toxicity, reproductive toxicity and toxicokinetics; or
(b)11th March 2009 in relation to all other tests.
(11) No person shall test a finished cosmetic product on animals where such testing is undertaken in order that the said product might satisfy any requirements of these Regulations or the Directive.
(12) Subject to paragraph (13) below, no person shall test any ingredient or combination of ingredients on animals in order to satisfy any requirement of these Regulations or the Directive using a method other than an alternative method where—
(a)an alternative method is listed in column 4 of Part 1 or 2 of Schedule 12 to these Regulations; and
(b)The ingredient or combination of ingredients is tested after the date given in column 5 of Part 1 or 2 of Schedule 12.
(13) No person shall test any ingredient or combination of ingredients on animals in order to satisfy any requirement of these Regulations or the Directive using a method other than an alternative method after 11th March 2009.
(14) The supply of any cosmetic product in respect of which a claim that the product or its ingredients have not been tested on animals appears on the packaging or in any document, notice, label, ring or collar accompanying or referring to the product is only permitted if—
(a)the manufacturer and his supplier have not carried out any such tests on the finished product, its prototype or on any of the ingredients contained in the finished product or its prototype;
(b)the manufacturer and his supplier have not commissioned any such tests on the finished product, its prototype or on any of the ingredients contained in the finished product or its prototype;
(c)the cosmetic product contains no ingredients which have been tested on animals by others for the purpose of developing new cosmetic products.
(15) No person shall supply a cosmetic product containing any substances classified as carcinogenic, mutagenic or toxic for reproduction of category 1, 2 or 3 in the approved supply list unless the substance is listed in Schedule 13 to these Regulations.
(16) Paragraphs (14) and (15) above shall not apply to any cosmetic product placed on the market in a Member State before 11th September 2004.
Commencement Information
I5Reg. 5 in force at 11.9.2004, see reg. 1(1)
6.—(1) The Secretary of State may authorise the use in a cosmetic product for a maximum period of three years of a particular substance, not being a substance or ingredient referred to in regulation 5(3) or a substance listed in Schedule 3 or 4.
(2) In giving an authorisation the Secretary of State may impose conditions relating to the use of a particular substance in a cosmetic product, and such conditions may relate to any matter which the Secretary of State considers appropriate including—
(a)the purpose of the substance;
(b)the type of cosmetic product;
(c)the maximum concentration of the substance in any cosmetic product; and
(d)information and marking requirements.
(3) The Secretary of State may on reasonable notice vary or revoke any authorisation given under paragraph (1) above.
(4) On giving, varying or revoking an authorisation, the Secretary of State shall arrange for the authorisation, variation or revocation, as the case may be, to be published in such manner as she considers appropriate for bringing it to the attention of persons who, in her opinion, would be likely to have an interest in it.
(5) No person shall be convicted of an offence under section 12 of the 1987 Act by reason of a cosmetic product containing a particular substance provided that at the time when but for this regulation an offence would have been committed—
(a)the use of that particular substance in that cosmetic product was duly authorised; and
(b)all of the conditions imposed by the authorisation were complied with.
Commencement Information
I6Reg. 6 in force at 11.9.2004, see reg. 1(1)
7.—(1) Subject to paragraphs (5)(b) and (9) to (12) below, no person shall supply a cosmetic product unless the packaging in which it is supplied bears, in lettering which is visible, indelible and easily legible, a list of its cosmetics ingredients (preceded by the word “ingredients”) in descending order of weight, the weight to be determined at the time the ingredients are added to the product.
(2) Subject to paragraphs (3), (4), (5)(a), (6) to (8), (13) and (14) below, no person shall supply a cosmetic product unless the container and packaging in which it is supplied bear the following particulars in lettering and other symbols (where appropriate) which is visible, indelible and easily legible—
(a)the name or trade name and the address or registered office of the manufacturer of the product or of the supplier thereof, being a manufacturer or supplier established within a Member State of the Community;
(b)in the case of a cosmetic product likely before the end of 30 months from the manufacture thereof to cease either to comply with the requirements of regulation 4 or to fulfil the purpose for which it was intended, the words “Best before ... ... ... ...” immediately followed by—
(i)the earliest date on which it is likely so to cease; or
(ii)an indication of where that date appears on the labelling,
and any particular precautions to be observed to ensure that the product does not so cease before that date;
(c)in the case of a cosmetic product—
(i)not falling within sub-paragraph (b) above; and
(ii)which may cease to comply with the requirements of regulation 4 after the container in which the product is contained has been opened,
the symbol given in Part II of Schedule 9 to these regulations together with an indication of the period of time after opening after which the cosmetic product is likely to cease to comply with the requirements of regulation 4;
(d)in the case of a cosmetic product containing a substance listed in column 2 of Schedule 4, the information specified in column 6 of that Schedule in relation to that substance;
(e)in the case of a cosmetic product containing a preservative listed in column 2 of Schedule 6, the information specified in column 6 of that Schedule in relation to that preservative;
(f)in the case of a cosmetic product containing a UV filter listed in column 2 of Schedule 7, the information specified in column 5 of that Schedule in relation to that UV filter;
(g)any particular precautions to be observed in use and any special precautionary information on a cosmetic product for professional use, in particular in hairdressing (not being precautions included in the information referred to in sub-paragraphs (b), (d), (e) and (f) above);
(h)a means of identifying the batch in which the product was manufactured (or, if the product was not manufactured in a batch, a reference from which the date and place of manufacture can be identified); and
(i)the function of the product unless this is clear from its presentation;
Provided that the requirements specified in sub-paragraphs (b), (c) and (h) above need not be complied with in relation to a cosmetic product which is the subject of a market research experiment.
(3) The particulars referred to in paragraph (2)(a) above may be abbreviated if such abbreviation does not prevent the person concerned from being identified.
(4) The date referred to in paragraph (2)(b) above shall include the month and the year or the day, month and year in the order given in this paragraph.
(5) The particulars referred to—
(a)in paragraph (2)(b) to (g) and (i) above shall be in English, but this shall not prohibit the additional use of other languages;
(b)in paragraph (1) above shall be in a language easily understood by the consumer.
(6) Where it is impossible for practical reasons for the particulars referred to in paragraph (2)(c) to (g) above to appear on the container and packaging, they shall appear on a leaflet, label, tag, tape or card enclosed with the cosmetic product, to which the consumer is referred either by abbreviated information or by the symbol given in Part 1 of Schedule 9, which must appear on the container and packaging; and where it is impracticable for reasons of size or shape for the particulars so to appear, they shall appear on a label, tag, tape or card attached to the product.
(7) Where it is impossible, for reasons of size, for the particulars referred to in paragraph (2)(h) above to appear on the container and packaging, it shall be sufficient for the said particulars to appear only on the packaging.
(8) In the case of a supply of soap which is not in a container, either the soap itself or the packaging in which it is exposed for supply or the container in which it was last contained before the supply shall bear the particulars referred to in paragraph (2)(a) and (h) above, and in so far as any of the particulars referred to in paragraph (2)(b) to (g) and (i) above are required they shall appear on a leaflet which shall be delivered to the buyer with the soap; and where either of the particulars referred to in paragraph (2)(a) and (h) above appears on the soap itself the requirement of indelibility shall apply only until it has been put into use.
(9) In relation to the compilation of the list of ingredients referred to in paragraph (1) above—
(a)the following shall not be regarded as cosmetic ingredients—
(i)impurities in the raw materials used;
(ii)subsidiary technical materials used in the preparation of the cosmetic product but not present in the final product;
(iii)materials used in strictly necessary quantities as solvents or as carriers for perfumes and aromatic compositions;
(b)perfume and aromatic compositions and their raw materials shall be referred to by the words “perfume” or “aroma” except where the substance—
(i)is listed in column 2 of Schedule 4 to these regulations; and
(ii)is required to be mentioned by a requirement in column 5 of that Schedule;
(c)ingredients in concentrations of less than 1 per cent may be listed in any order after those in concentrations of 1 per cent or more;
(d)colouring agents may be listed in any order after the other ingredients, in accordance with the colour index number or denomination given in Schedule 5;
(e)for decorative cosmetic products marketed in several colour shades, all colouring agents used in the range may be listed, provided that the words “may contain” or the symbol “+/-” are added; and
(f)an ingredient shall be identified by the name provided for in the International Nomenclature of Cosmetic Ingredients (INCI) or in the absence of such identification, by its chemical name, its CTFA name, its European Pharmacopoeia name, its International Non-proprietary Name (INN) as recommended by the World Health Organization, its EINECS, IUPAC or CAS identification reference or its colour index number(9).
(10) Subject to paragraph (11) below, where a cosmetic product has no packaging or it is impossible for practical reasons for the list of ingredients referred to in paragraph (1) above to appear on the packaging, the list shall appear on the container; and where a cosmetic product is supplied or delivered pursuant to any supply in neither a container nor packaging, the list shall appear on the container in which the product is exposed for supply or a notice in immediate proximity to that container.
(11) Subject to paragraph (12) below, where it is impossible for practical reasons for the list of ingredients referred to in paragraph (1) above to appear on the packaging or container of a cosmetic product, it shall appear on a leaflet, label, tag, tape or card enclosed with the product, to which the consumer is referred either by abbreviated information or by the symbol given in Part 1 of Schedule 9, which must appear on the packaging; and where it is impracticable for reasons of size and shape for the list so to appear, it shall appear on a label, tag, tape or card attached to the cosmetic product.
(12) In the case of soap, bathballs and other small products, where it is impracticable for reasons of size or shape for the list of ingredients referred to in paragraph (1) above to appear on an enclosed leaflet or on a label, tag, tape or card enclosed with or attached to the product, it shall appear on a notice in immediate proximity to the consumer in which the cosmetic product is exposed for sale.
(13) Where two or more cosmetic products are supplied together as a single item, each product being in a separate container and the containers being enclosed together in packaging which bears clear and conspicuous instructions to the effect that the products must be mixed together in specified proportions before use, the particulars referred to in paragraph (2)(d) to (g) above shall appear on an enclosed leaflet and an indication shall appear on both the containers and the packaging referring the consumer to the information in the leaflet.
(14) Where a cosmetic product other than soap is supplied or delivered pursuant to a supply in neither a container nor packaging, the particulars referred to in paragraph (2) above shall appear on the container in which the product is exposed for supply or a notice in immediate proximity to that container.
(15) Paragraphs 7(2)(c) and 7(9)(b) above shall not apply to cosmetic products placed on the market in the Community prior to 11th March 2005.
Commencement Information
I7Reg. 7(1)(2)(a)(b)(d)-(i)(3)-(9)(a)(c)-(f)(10)-(15) in force at 11.9.2004, see reg. 1(1)
I8Reg. 7(2)(c)(9)(b) in force at 11.3.2005, see reg. 1(2)
8.—(1) For the purposes of regulations 9 (except regulation 9(5) and (6)), 10, 11 and 12—
(a)“responsible person” means, in relation to a relevant cosmetic product,
(i)the manufacturer of that product;
(ii)the manufacturer’s agent;
(iii)the person to whose order that cosmetic product is manufactured; or
(iv)where the manufacturer or the person to whose order the cosmetic product is manufactured is not established in the Community and either—
(aa)the manufacturer has not appointed an agent; or
(bb)the manufacturer’s agent is not the supplier of that cosmetic product,
the person who first supplies the cosmetic product in the Community;
(b)“competent authority” means a body responsible for requiring and receiving the information provided for in Articles 7.3, 7a.1 and 7a.4 of the Directive and granting and refusing requests for confidentiality pursuant to Article 4 of the Confidentiality Directive, and which is—
(i)a United Kingdom competent authority pursuant to paragraph (2) below; or
(ii)for the time being a competent authority of a Member State other than the United Kingdom, having been notified as a competent authority by the Member State concerned to the Commission pursuant to Articles 7.3 and 7a.5 of the Directive and Article 10 of the Confidentiality Directive.
(2) The United Kingdom competent authority shall be the Secretary of State provided that she may from time to time appoint such person as she thinks fit to be a United Kingdom competent authority in addition to or in substitution for herself.
Commencement Information
I9Reg. 8 in force at 11.9.2004, see reg. 1(1)
9.—(1) Subject to paragraph (8) below, where a cosmetic product is manufactured or supplied in the United Kingdom a responsible person shall for control purposes keep easily accessible to a United Kingdom competent authority at the address or registered office specified on the container or packaging of the cosmetic product in accordance with regulation 7(2)(a) above the following information—
(a)the qualitative and quantitative composition of the product, except to the extent that the product is composed of any perfume or perfume composition, in which case the responsible person shall only be required to keep the name and code number of the perfume or perfume composition and the identity of the supplier;
(b)the physico-chemical and microbiological specifications of the raw materials and the finished product and the purity and microbiological control criteria of the cosmetic product;
(c)the method of manufacture which shall be in accordance with good manufacturing practice, that is to say that the cosmetic product shall be manufactured in such a way that under normal and reasonably foreseeable conditions of use it shall not endanger human health or safety;
(d)an assessment of the safety for human health of the finished product taking into consideration the matters specified in paragraph (2) below;
(e)a specific assessment of the safety for human health of the finished product taking into consideration the matters specified in paragraph (2) below in respect of cosmetic products intended for use on children under the age of 3 and for cosmetic products intended exclusively for use in external intimate hygiene;
(f)the name and address of the person or persons, qualified in accordance with paragraph (5) below, responsible for the assessments referred to in sub-paragraphs (d) and (e) above;
(g)existing data on undesirable effects on human health resulting from use of the cosmetic product;
(h)proof of the effect claimed for the cosmetic product, where justified by the nature of the effect or product; and
(i)data on any animal testing performed by the manufacturer, his agents or suppliers, relating to the development or safety evaluation of the product or its ingredients, including any animal testing performed to meet the legislative or regulatory requirements of countries which are not Member States;
(2) The assessments referred to in paragraphs (1)(d) and (1)(e) above shall be carried out in accordance with the principles of good laboratory practice referred to in Article 1 of European Parliament and Council Directive 2004/10/EC (10) on the application of the principles of good laboratory practice and the verification of their applications for tests on chemical substances and shall take particular account of the following—
(a)the general toxicological profile of each ingredient used;
(b)the chemical structure of each ingredient;
(c)the level of exposure of each ingredient;
(d)the specific exposure characteristics of the areas on which the cosmetic product will be applied; and
(e)the specific exposure characteristics of the class of individuals for whom the cosmetic product is intended.
(3) Subject to paragraph (4) below and without prejudice to the protection in particular of commercial secrecy and of intellectual property rights where a cosmetic product is manufactured or supplied in the United Kingdom a responsible person shall ensure that the information specified in paragraphs (1)(a) and (1)(g) above shall be made easily accessible to the public by any appropriate means.
(4) For the purposes of paragraph (3) above, the quantitative information required under paragraph (1)(a) shall be limited to information relating to dangerous substances covered by Directive 67/548/EEC as amended.
(5) The person referred to in paragraph (1)(f) must be—
(a)subject to paragraph (6) below, the holder of an appropriate European diploma within the meaning of section 4A of the Pharmacy Act 1954(11) or any other person who has the right, granted by a competent authority in a Member State, to take up and pursue the activities of a pharmaceutical chemist;
(b)subject to paragraph (6) below, a person who is entitled to be registered under section 3(1) of the Medical Act 1983(12) as a fully registered medical practitioner and who has the right, granted by a competent authority in a Member State, to take up and pursue the activities of a doctor; or
(c)the holder of a diploma within the meaning of regulation 2(1) of the European Communities (Recognition of Professional Qualifications) Regulations 1991(13) showing that the holder has the qualifications required to practise as a chartered biologist or that he has the qualifications required to practise as a chartered chemist or that he has the qualifications required to practise a profession equivalent to the profession of chartered biologist or chartered chemist in a Member State other than the United Kingdom.
(6) Any diploma or other evidence of qualification required for the purposes of paragraph (5)(a) or (b) above shall satisfy that requirement only if—
(a)the education and training attested were received mainly within the European Community; or
(b)the holder has spent at least three years in lawful pursuit in a Member State of the relevant profession, and such professional experience has been certified by a competent authority in a Member State (being a State which recognised a diploma or other evidence of qualification obtained in a non-Member State).
(7) Where the responsible person is the manufacturer or the person who first imports the cosmetic product into the Community he must possess appropriate experience or an appropriate level of professional qualification in accordance with the legislation and practice of the United Kingdom if it is the place of manufacture or first importation.
(8) Where the manufacturer manufactures a cosmetic product at two or more places within the Community, and one of those places is within the United Kingdom, the responsible person may choose a single place of manufacture within the Community where the information referred to in paragraph (1) above will be kept available provided that, if requested by a United Kingdom competent authority, he informs the said authority of the location at which the said information is to be kept.
(9) Where the information referred to in paragraph (1) above is to be kept accessible to a United Kingdom competent authority it must be in English or a language readily understood by the said authority.
(10) Paragraphs 9(1)(e), 9(1)(i), 9(2)(d) and 9(2)(e) above shall not apply in respect of cosmetic products placed on the market in the Community prior to 11th September 2004.
Commencement Information
I10Reg. 9 in force at 11.9.2004, see reg. 1(1)
10. Where the place of manufacture or initial importation into the Community of a type of cosmetic product is within the United Kingdom, the responsible person shall notify a United Kingdom competent authority of the address of the place of manufacture or, as the case may be, initial importation into the Community of that type of cosmetic product before its first supply in the Community.
Commencement Information
I11Reg. 10 in force at 11.9.2004, see reg. 1(1)
11.—(1) A United Kingdom competent authority may, where difficulties are encountered in providing prompt and appropriate medical treatment, require that any holder of appropriate and adequate information on substances used in cosmetic products make such information available to it, where the difficulties referred to may be overcome or eased by the provision of the said information.
(2) Where the information referred to in paragraph (1) above is made available, the United Kingdom competent authority shall ensure that it is used solely for the purposes of the treatment referred to in paragraph (1) above.
Commencement Information
I12Reg. 11 in force at 11.9.2004, see reg. 1(1)
12.—(1) Without prejudice to the provisions of regulations 4, 5, 9 and 12, a responsible person who for reasons of trade secrecy wishes not to include one or more cosmetic ingredients in the list of cosmetic ingredients referred to in regulation 7(1) above shall submit a request to that effect to the competent authority.
(2) In this regulation “applicant” means a responsible person who submits a request for confidentiality.
(3) The applicant shall ensure that—
(a)the request for confidentiality includes the particulars laid down in Part I of Schedule 10; and
(b)any amendments to the particulars provided for in sub-paragraph (a) above are communicated as quickly as possible to the competent authority and, in particular, that all changes to the names of cosmetic products containing the cosmetic ingredient in respect of which confidentiality is or has been sought, are communicated to the competent authority at least 15 days before those cosmetic products are supplied under their new names.
(4) Within four months of the receipt of a request for confidentiality in respect of which the requirements of paragraph (3)(a) above are satisfied, the competent authority shall examine the request and inform the applicant in writing of its decision.
(5) If the competent authority decides to grant its approval to the applicant’s request it shall, in notifying the applicant of its decision, in accordance with paragraph (4) above, also notify him of the registration number which will replace the cosmetic ingredient in question in the list referred to in regulation 7(1), the said number to be allocated to the product in accordance with the procedure provided for in Part II of Schedule 10.
(6) If the competent authority decides to refuse to grant its approval to the applicant’s request it shall, in its notification of this refusal, include a statement of the reasons for refusal and a clear explanation of appeals procedures and their time limits.
(7) In exceptional cases the competent authority may inform the applicant in writing that a period of two months in addition to the four-month period referred to in paragraph (4) above is required for the examination of the request.
(8) Subject to paragraphs (9), (10), (11) and (12) below, a decision granting confidentiality shall be valid for a period of five years.
(9) An applicant may, by submitting a reasoned request to the competent authority, request that the period of confidentiality referred to in paragraph (8) above be extended.
(10) In the event of a reasoned request being submitted in accordance with paragraph (9) above, the competent authority shall deal with the request in accordance with paragraphs (4), (5) and (6) above.
(11) Any extension of the period of confidentiality shall not exceed three years.
(12) The competent authority may withdraw its approval to an applicant’s request for confidentiality if it considers this appropriate taking into account—
(a)any amendments to the particulars provided for in paragraph (3)(a) above which are communicated to it in accordance with paragraph (3)(b) above; and
(b)any new information which comes to its attention which makes it imperative, particularly for compelling reasons of public health, for it to so act,
and in withdrawing its approval the competent authority shall comply with the provisions of paragraphs (4), (6) and (7) above.
Commencement Information
I13Reg. 12 in force at 11.9.2004, see reg. 1(1)
13.—(1) Subject to paragraph (2) below, any contravention of a requirement of these regulations with the exception of regulations 5(7)-5(13) shall be treated for all purposes as though it were a contravention of a requirement of safety regulations made under section 11 of the 1987 Act.
(2) The term of imprisonment to which a person guilty of an offence under regulations 9, 10 or 11 shall be liable on summary conviction shall not exceed three months.
Commencement Information
I14Reg. 13 in force at 11.9.2004, see reg. 1(1)
14.—(1) Any person who contravenes regulation 5(7), 5(8), 5(9),5(10), 5(11),5(12) or 5(13) or causes or permits another person to contravene those regulations, shall be guilty of an offence.
(2) Any person guilty of an offence under paragraph (1) above shall be liable, on summary conviction, to a fine not exceeding the statutory maximum or to imprisonment not exceeding three months and, on conviction on indictment, to a fine or to imprisonment not exceeding six months.
(3) Where an offence under paragraph (1) committed by a body corporate is proved—
(a)to have been committed with the consent or connivance of an officer, or
(b)to be attributable to any neglect on his part,
the officer as well as the body corporate shall be guilty of that offence and shall be liable to be proceeded against and punished accordingly.
(4) In paragraph (3), “officer” in relation to a body corporate, means a director, manager, secretary or other similar officer of the body, or a person purporting to act in any such capacity.
(5) If the affairs of the body corporate are managed by its members, paragraph (3) shall apply in relation to the acts and defaults of a member in connection with his functions of management as if he were a director of the body corporate.
(6) Where an offence under paragraph (1) committed by a partnership in Scotland is proved—
(a)to have been committed with the consent and connivance of the partner, or
(b)to be attributable to any neglect on his part,
the partner as well as the partnership shall be guilty of that offence and liable to be proceeded against and punished accordingly.
(7) In paragraph (6), partner includes a person purporting to act as a partner.
Commencement Information
I15Reg. 14 in force at 11.9.2004, see reg. 1(1)
15. For the purposes of enforcing regulations 5(7), 5(8), 5(9), 5(10), 5(11),5(12) and 5(13), those regulations shall be treated as if they were safety regulations made under section 11 of the 1987 Act provided that section 12 of that Act shall not apply.
Commencement Information
I16Reg. 15 in force at 11.9.2004, see reg. 1(1)
16.—(1) No proceedings shall be brought and no enforcement action taken in respect of—
(a)any failure to comply with regulations 4, 5 (with the exception of 5(11) and 5(12)), 7, 9, 10 and 11 in any case in which the cosmetic product is supplied for the purposes of exporting that product to any country which is not a Member State; or
(b)any failure to comply with regulation 7(5)(a) in any case in which the enforcement authority is satisfied that the person supplying the cosmetic product reasonably believes that it will not be used in the United Kingdom.
(2) No proceedings shall be brought and no enforcement action taken in respect of any contravention of regulation 5(7) of the Cosmetic Products (Safety) Regulations 2003(14) once these regulations have come into force.
(3) No proceedings shall be brought and no enforcement action taken in respect of any contravention or failure to comply with these Regulations insofar as an entry in Part 2 of Schedule 1 to these Regulations is concerned in respect of a new substance in such an entry or where the cosmetic product in question complied with the entry as it appeared before 24th March 2005 and where the cosmetic product in question was—
(i)placed on the market before 24th March 2005; and
(ii)supplied before 24th September 2005.
(4) For the purposes of this regulation, “enforcement action” means any action taken pursuant to or in connection with sections 13, 14, 16, 17, 28, 29, 30 or 31 of the 1987 Act.
Commencement Information
I17Reg. 16 in force at 11.9.2004, see reg. 1(1)
17. Any test of goods purchased under section 28 or seized under section 29 of the 1987 Act (which relate to enforcement) by or on behalf of an enforcement authority for the purpose of ascertaining whether the provisions of these Regulations have been contravened shall in all cases be carried out in accordance with the provisions of paragraphs 2 to 5 Schedule 11 and any test for which a method is specified in paragraph 6 of Schedule 11 shall be carried out in accordance with that method.
Commencement Information
I18Reg. 17 in force at 11.9.2004, see reg. 1(1)
18. No proceedings for an offence under these Regulations shall be commenced after—
(a)the end of the period of three years beginning with the date of the commission of the offence, or
(b)the end of the period of one year beginning with the date of the discovery of the offence by the prosecutor,
whichever is earlier.
Commencement Information
I19Reg. 18 in force at 11.9.2004, see reg. 1(1)
Gerry Sutcliffe,
Parliamentary Under Secretary of State for Employment Relations, Competition and Consumers
Department of Trade and Industry
17th August 2004
Regulations 1(3), 1(4) and 16(3)
Commencement Information
I20Sch. 1 Pt. 1 in force at 11.9.2004, see reg. 1(1)
Schedules 3,4 and 6 to these Regulations shall have effect until 24th March 2005 with the insertion of the entries set out in Part 1 of this Schedule as they appear in the Cosmetic Products (Safety) Regulations 2003(15) in place of the corresponding entries in the those Schedules to these Regulations.
| Substance | Reference number or entry number | Schedule and Part number in the Cosmetic Products (Safety) Regulations 2003 |
|---|---|---|
| Benzoyl peroxide | 90 | Schedule 3, Part 1 |
| Hydroquinone monobenzyl, monoethyl and monomethyl ethers | 391 | Schedule 3, Part 1 |
| 4-Methoxyphenol | 458 | Schedule 3, Part 1 |
| Secondary dialkanolamines | 643 | Schedule 3, Part 1 |
| Hydroquinone | 14 | Schedule 4, Part 1 |
| Fatty acid dialkanolamides | 60 | Schedule 4, Part 1 |
| Monoalkanolamines | 61 | Schedule 4, Part 1 |
| Trialkanolamines | 62 | Schedule 4, Part 1 |
| 1,2-Dibromo-2,4-dicyanobutane [Methyldibromo glutaronitrile] | 36 | Schedule 6, Part 1 |
Commencement Information
I21Sch. 1 Pt. 2 in force at 11.9.2004, see reg. 1(1)
Subject to regulation 1(3), the entries referred to in Part 2 of this Schedule shall not form part of the Schedules referred to in column 3 below until 24th March 2005.
| Substance | Reference number or entry number | Schedule and Part number in these Regulations |
|---|---|---|
| Secondary alkyl- and alkanolamines and their salts | 643 | Schedule 3, Part 1 |
| Hydroquinone monobenzyl and monoethyl ethers | 391 | Schedule 3, Part 1 |
| Hydroquinone | 14 | Schedule 4, Part 1 |
| Fatty acid dialkylamides and dialkanolamides | 60 | Schedule 4, Part 1 |
Monoalkylamines, Monoalkanolamines and their salts | 61 | Schedule 4, Part 1 |
| Trialkylamines, trialkanolamines and their salts | 62 | Schedule 4, Part 1 |
2,4-Diamino-pyrimidine-3-oxide (CAS No 74638-76-9) | 93 | Schedule 4, Part 1 |
| Benzoyl peroxide | 94 | Schedule 4, Part 1 |
| Hydroquinone methyl ether | 95 | Schedule 4, Part 1 |
| 1,2-Dibromo-2,4-dicyanobutane [Methyldibromo glutaronitrile] | 36 | Schedule 6, Part 1 |
Regulation 3(1)
Commencement Information
I22Sch. 2 in force at 11.9.2004, see reg. 1(1)
1. Council Directive 82/368/EEC (N.J. No. L167, 15.6.82, p.1).U.K.
2. Commission Directive 82/147/EEC (O.J. No. L63, 6.3.82, p.26).U.K.
3. Commission Directive 83/191/EEC (O.J. No. L109, 26.4.83, p.25).U.K.
4. Commission Directive 83/341/EEC (O.J. No. L188, 13.7.83, p.15).U.K.
5. Council Directive 83/574/EEC (O.J. No. L332, 28.11.83, P.38.)U.K.
6. Commission Directive 83/496/EEC (O.J. L275, 8.10.83, P.20).U.K.
7. Commission Directive 84/415/EEC (O.J. No. L228, 25.8.84, p.31).U.K.
8. Commission Directive 85/391/EEC (O.J. L224, 22.8.85, p.40).U.K.
9. Commission Directive 86/179/EEC (O.J. No. L138, 24.5.86, p.40).U.K.
10. Commission Directive 86/199/EEC (O.J. No. L149, 3.6.86, p.38).U.K.
11. Commission Directive 87/137/EEC (O.J. No. L56, 26.2.87, p.20).U.K.
12. Commission Directive 88/233/EEC (O.J. L105, 26.4.88, p.11).U.K.
13. Council Directive 88/667/EEC (O.J. No. L382, 31.12.88, p.46).U.K.
14. Commission Directive 89/174/EEC (O.J. No, L64, 8.3.89, p.10).U.K.
15. Council Directive 89/679/EEC (O.J. No. L398, 30.12.89, p.25).U.K.
16. Commission Directive 90/12/EEC (O.J. No. L71, 17.3.90, p.40).U.K.
17. Commission Directive 91/184/EEC (O.J. No. L91, 12.4.91, p.59).U.K.
18. Commission Directive 92/8/EEC (O.J. No. L70, 17.3.92, p.23)U.K.
19. Commission Directive 92/86/EEC (O.J. No.L325, 11.11.92, p.18).U.K.
20. Commission Directive 93/47/EEC (O.J. No. L203, 13.8.93, p.24).U.K.
21. Council Directive 93/35/EEC (O.J. No. L151, 23.6.93, p.32).U.K.
22. Commission Directive 94/32/EC (O.J. No. L181, 15.7.94, p.31).U.K.
23. Commission Directive 95/34/EC (O.J. No. L167, 18,7.95, p.19)U.K.
24. Commission Directive 96/41/EC (OJ No. L198, 8.8.96, p.36).U.K.
25. Commission Directive 97/18/EC (O.J. No. L114, 1.5.97, p.43).U.K.
26. Commission Directive 97/45/EC (O.J. No. L196, 24.7.97, p.77).U.K.
27. Commission Directive 98/16/EC (O.J. No. L77, 14.3.98, p.44).U.K.
28. Commission Directive 98/62/EC (O.J. No. L253, 15.9.98, p.20).U.K.
29. Commission Directive 2000/6/EC (O.J. No. L56, 1.3.00, p.42).U.K.
30. Commission Directive 2000/11/EC (O.J. No. L65, 14.3.00, p.22).U.K.
31. Commission Directive 2000/41/EC (O.J. No. L145, 20.6.00, p.25).U.K.
32. Commission Directive 2003/1/EC (O.J. No. L102, 18.4.02, p.19).U.K.
33. Commission Directive 2003/1/EC (O.J. No. L5, 10.1.03, p.14).U.K.
34. Commission Directive 2003/16/EC (O.J. No. L46, 20.2.03, p.24).U.K.
35. Commission Directive 2003/15/EC (O.J. No. L66, 11.3.03, p.26).U.K.
36. Commission Directive 2003/80/EC (O.J. No. L224, 6.9.2003, p.27).U.K.
37. Commission Directive 2003/83/EC (O.J. No. L238, 25.9.03, p.23)U.K.
Regulations 5(2) and 6(1)
The alphabetical list set out in column 2 of this Schedule contains one or more of the names of each of the substances referred to in regulation 5(2); in certain cases a name is given of a group of substances, the names of particular examples of which are also given, and in such a case all substances comprised in the group are included, whether or not more specifically named.
The references given in columns 3 and 4 are for information only. Those in column 3 are cross-references to other names listed for the same substance (except that where a name is that of a group of substances, the cross-references are to particular examples of that group, and any cross-reference in parenthesis is to the name of a group of substances within which the particular substances falls).
Regulation 1(3) provides that until 24th March 2005 entries 90, 391, 458 and 643 shall be inserted into Part 1 of this Schedule as they appear Part 1, Schedule 3 to the Cosmetic Products (Safety) Regulations 2003. From 24th March 2005 the above entries shall have effect as they appear in Part 1 of this Schedule.
Commencement Information
I23Sch. 3 Pt. 1 in force at 11.9.2004, see reg. 1(1)
| (1) | (2) | (3) | (4) |
|---|---|---|---|
| Number in this Schedule | Name of substance | Cross-reference to this Schedule | Cross-reference to Annex II of the Directive |
| 1 | Acenocoumarol (INN) | 397 | 254 |
| 2 | Acetonitrile | — | 393 |
| 3 | 3-(α-Acetonylbenzyl)-4-hydroxycoumarin and its salts | 399, 762 | 203 |
| 4 | 2-Acetoxethyltrimethylammonium hydroxide and its salts | 6 | 2 |
| 5 | 2-Acetylamino-5-chlorobenzoxazole | 163 | 1 |
| 6 | Acetylcholine and its salts | 4 | 2 |
| 7 | Acetylene chlorides | 250, 759 | 126 |
| 8 | Acetylenic alcohols, their esters, ethers and salts | 17 | 16 |
| 9 | Acetylethyltetramethyltetralin (AETT) | 342 | 362 |
| 10 | 7α-Acetylthio-3-oxopregn-4-ene-17α,17β-propionolactone | 652 | 4 |
| 11 | Aconitine and its salts | — | 12 |
| 12 | Aconitum napellus L. (leaves, roots and galenical preparations) | — | 11 |
| 13 | Adonis vernalis L. and its preparations | — | 13 |
| 14 | Adrenaline | 270,315 | 14 |
| 15 | Alkali pentacyanonitrosylferrate(2-)- | 605-6, 647-8 | 255 |
| 16 | O-Alkyldithiocarbonic acids, salts of | 763 | 336 |
| 17 | Alkyne alcohols, their esters, ethers and salts | 8 | 16 |
| 18 | Alloclamide (INN) and its salts | 22 | 18 |
| 19 | Allyl isothiocynate | — | 18 |
| 20 | 2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts | — | 224 |
| 21 | N-Allylnormorphine, its salts and ethers | 494 | 20 |
| 22 | 2-Allyloxy-4-chloro-N-[2-(diethylamino)ethyl]-benzamide and its salts | 18 | 19 |
| 23 | Alypine and its salts | 45, 107 | 143 |
| 24 | Ambenonium chloride (INN) | (529) | 132 |
| 25 | 4-(or p-)Aminobenzonic acid esters | — | 167 |
| 26 | 2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts | — | 29 |
| 27 | Aminocaproic acid (INN) and its salts | 31 | 7 |
| 28 | 2-Amino-5-chlorobenzoxazole | 769 | 24 |
| 29 | 4-Amino-N-(2-diethylaniaminoethyl)benzamide, its salts and derivatives | 610 | 25 |
| 30 | Aminoheptane, its isomers and salts | 751 | 25 |
| 31 | 6-Aminohexanoic acid and its salts | 27 | 7 |
| 32 | α-(Aminomethyl)-3,4-dihydroxybenzyl alcohol and its salts | 519-520 | 257 |
| 33 | 4-Amino-N1o-methylfolic acid | 452 | 6 |
| 34 | 2-Amino-6-methylheptane and its salts | 288, 525 | 28 |
| 35 | 2-Amino-4-methylhexane and its salts | 289, 471 | 30 |
| 36 | 2-Amino-4-nitrophenol | — | 383 |
| 37 | 2-Amino-5-nitrophenol | — | 384 |
| 38 | 4-Amino-2-nitrophenol | — | 412 |
| 39 | 4-(or p-)Aminosalicylic acid and its salts | — | 31 |
| 40 | Aminotoluenes, their isomers, salts and halogenated and sulphonated derivatives | 719 | 32 |
| 41 | Aminoxylenes, their isomers, salts and halogenated and sulphonated derivatives | 765 | 33 |
| 42 | Amitriptyline (INN) and its salts | 284 | 146 |
| 43 | Ammi majus and its galenical preparations | — | 35 |
| 44 | Amphetamine (INN), its salts and derivatives and salts of those derivatives | (681) | 21 |
| 45 | Amydricaine and its salts | 23, 107 | 143 |
| 46 | Amylene chloride | 251 | 36 |
| 47 | Amyl 4-dimethylaminobenzoate, mixed isomers | 534 | 381 |
| 48 | Amyl nitrites | — | 247 |
| 49 | Amylobarbitone and its salts | (69) | 220 |
| 50 | Amylocaine and its salts | 282 | 50 |
| 51 | Anamirta cocculus L. (fruit) | — | 106 |
| 52 | Substances with androgenic effect | — | 37 |
| 53 | Aniline, its salts and halogenated and sulphonated derivatives | — | 22 |
| 54 | Anthracene oil | — | 38 |
| 55 | Anti-androgens with steroid structure | — | 390 |
| 56 | Antibiotics | — | 39 |
| 57 | Antimony and its compounds | — | 40 |
| 58 | Apocynum cannabinum L. and its preparations | — | 41 |
| 59 | Apomorphine and its salts | 697 | 42 |
| 60 | Apronalide | 420 | 216 |
| 61 | Arecoline | 482 | 238 |
| 62 | Aristolochic acid and its salts | — | 365 |
| 63 | Arsenic and its preparations | — | 43 |
| 64 | Atropa belladonna L. and its preparations | — | 44 |
| 65 | Antropine, its salts and derivatives | — | 45 |
| 66 | Azacyclonol (INN) and its salts | 305 | 286 |
| 67 | Azamethonium bromide (INN) | (473) | 121 |
| 68 | Barbitone and its salts | (69) | 220 |
| 69 | Barbiturates | various | 220 |
| 70 | Barium salts (except barium sulphate, barium sulphide under the condition laid down in Part I of Schedule 4 for alkaline earth sulphides, and lakes, salts and pigments prepared from those colouring agents identified in column 1 of Schedule 5 by “*” immediately after the name or colour index number) | — | 46 |
| 71 | Bemegride (INN) and its salts | 337, 338 | 183 |
| 72 | Benactyzine (INN) | 258 | 157 |
| 73 | Bendrofluazide and its derivatives | 74, 89 | 53 |
| 74 | Bendroflumethiazide (INN) and its derivatives | 73, 89 | 53 |
| 75 | Benzamine and its salts | 744 | 51 |
| 76 | Benzatropine (INN) and its salts | 301 | 158 |
| 77 | Benzazepines, their salts and derivatives | 88 | 49 |
| 78 | Benzene | — | 47 |
| 79 | Benzene-1,2-diol | 152, 630 | 408 |
| 80 | Benzene-1,2,3-triol | 631 | 409 |
| 81 | 2-Benzhydryloxyethyldimethylamine and its salts | 296 | 339 |
| 82 | Benzidine | 243 | 26 |
| 83 | Benzilonium bromide (INN) | 93 | 60 |
| 84 | 2-Benziloyloxymethyl-1,1-dimethylpyrrolidinium methyl sulphate | 602 | 239 |
| 85 | Benzimidozolone | 86, 267 | 48 |
| 86 | Benzimidazol-2(3H)-one; | 85, 267 | 48 |
| 87 | Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol (except natural content of essences) | 211 | 357 |
| 88 | Benzodiazepines, their salts and derivatives | 77 | 49 |
| 89 | Benzothiadiazine and its derivatives | 73, 74 | 53 |
| 90 | ENTRY DELETED | ||
| 91 | 3-(N-Benzylhydrazinocarbonyl)-5-methylisoxazole | 415 | 52 |
| 92 | Benzylideneacetone | 567 | 356 |
| 93 | 3-Benzyloxy-1,1-diethylpyrrolidine hydrobromide | 83 | 60 |
| 94 | 4-Benzyloxyphenol | (391), 487 | 178 |
| 95 | 2-[Benzyl-N-(2-pyridyl)amino]ethyldimethylamine | 626, 748 | 347 |
| 96 | Bergapten(e) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (357) | 358 |
| 97 | Beryllium and its compounds | — | 54 |
| 98 | Betamethasone (INN) | (361) | 300 |
| 99 | Betoxycaine (INN) and its salts | 257 | 23 |
| 100 | BHC (ISO) (gamma-BHC) | 370, 372, 428 | 195 |
| 101 | Bietammiverine (INN) | 261 | 287 |
| 102 | 1,6-Bis(2-chloroethylamino)-1,6-dideoxymannitol and its salts | 436 | 89 |
| 103 | 2-[Bis(2-chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane 2-oxide and its salts | 106, 231 | 88 |
| 104 | N,N-Bis(2-chloroethyl)methylamine and its salts | 159 492 | 87 |
| 105 | N,N-Bis(2-chloroethyl)methylamine N-oxide and its salts | 493 | 86 |
| 106 | N,N-Bis(2chloroethyl)-1,3,2-oxazaphosphinan-2-ylamine P-oxide and its salts | 103, 231 | 88 |
| 107 | 1,1-Bis(dimethylaminomethyl)propyl benzoate and its salts | 23, 45 | 143 |
| 108 | Bis(hydroxyalkyl)amines, not further N-substituted | 255, 274, (643) | 411 |
| 109 | 2,2-Bis(hydroxymethyl)butan-1-ol trinitrate | 616 | 206 |
| 110 | 2,6-Bis(β-hydroxyphenethyl)-1-methylpiperidine and its salts | 430 | 219 |
| 111 | 3,3-Bis(4-hydroxyphenyl)phthalide | 560 | 417 |
| 112 | Bis(8-hydroxyquinolinium) sulphate, except for the uses provided for in entry number 51 in Part 1 of Schedule 4 | (401, 533) | 395 |
| 113 | Bithionol (INN) | 708 | 352 |
| 114 | Bretylium tosilate (INN) (Bretylium tosylate) | 117 | 56 |
| 115 | Bromine, elemental | — | 55 |
| 116 | Bromisoval (INN) | 119 | 58 |
| 117 | p-Bromobenzylethyldimethylammonium p-toluenesulphonate | 114 | 56 |
| 118 | 2-Bromo-2-ethylbutyrylurea | 148 | 57 |
| 119 | 2-Bromo-3-methylbutylrylurea | 116 | 58 |
| 120 | 1-p-Bromophenyl-l-(2-pyridyl)-3-dimethylaminopropane and its salts | 121 | 59 |
| 121 | Brompheniramine (INN) and its salts | 120 | 59 |
| 122 | Brucine | — | 62 |
| 123 | Butanilicaine (INN) and its salts | 466 | 90 |
| 124 | Butobarbitone and its salts | (69) | 220 |
| 125 | Butopiprine (INN) and its salts | 127 | 288 |
| 126 | 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide and its salts | 190 | 129 |
| 127 | 2-Butoxyethyl phenyl(piperidino)acetate and its salts | 125 | 288 |
| 128 | 1-Butyl-3-(N-crotonoylsulphanilyl)urea | — | 108 |
| 129 | 4-Butyl-1,2-diphenylpylpyrazolidine-3,5-dione | 566 | 67 |
| 130 | 4-tert-Butyl-3-methhoxy-2,6-dinitrotoluene | 490 | 414 |
| 131 | 4-Butyl-l-phenylpyrazolidine-3,5-dione | 486 | 64 |
| 132 | 1-Butyl-3-(p-methylenzenesulphonyl)urea | 718 | 65 |
| 133 | 1-Butyl-3-sulphanilylurea | 149 | 66 |
| 134 | 4-Butylthiobenzhydryl 2-(dimethylamino)ethyl sulphide | 142 | 140 |
| 135 | 1-tert-Butyl-3,4,5-trimethyl-2,6-dinitrobenzene | 491 | 422 |
| 136 | Cadmium and its compounds | — | 68 |
| 137 | Calabar bean | 588 | 281 |
| 138 | Calciferol | 317, (761) | 335 |
| 139 | Cantharides, Cantharis vesicatoria | 650 | 69 |
| 140 | Cantharidin | 379 | 70 |
| 141 | Captan (ISO) | 737 | 370 |
| 142 | Captodiame (INN) | 134 | 140 |
| 143 | Caramiphen (INN) and its salts | 570 | 169 |
| 144 | N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts | 419 | 156 |
| 145 | Carbazole, nitroderivatives of | 510 | 72 |
| 146 | Carbon disulphide | — | 73 |
| 147 | Carbon tetrachloride | 693 | 315 |
| 148 | Carbromal (INN) | 118 | 57 |
| 149 | Carbutamide (INN) | 133 | 66 |
| 150 | Carisoprodol (INN) | 480 | 235 |
| 151 | Catalase | — | 74 |
| 152 | Catechol | 79, 630 | 408 |
| 153 | Cells, tissues or products of human origin | — | 416 |
| 154 | Cephaeline and its salts | — | 75 |
| 155 | Chenopodium ambrosioides (essential oil) | — | 76 |
| 156 | Cherry laurel water | 621 | 291 |
| 157 | Chloral hydrate | 735 | 77 |
| 158 | Chlorine | — | 78 |
| 159 | Chlormethine (INN) and its salts | 104, 492 | 87 |
| 160 | Chlormezanone (INN) | 174 | 91 |
| 161 | 4-Chlorobenzene-1,3-disulfonamide | 193 | 85 |
| 162 | 5-Chloro-1,3-benzoxazol-2(3H)-one | 185 | 82 |
| 163 | N-5-Chlorobenzoxazol-2-ylacetamide | 5 | 1 |
| 164 | 2-Chloro-9-[3-dimethylamino-6-methylpyrimidine | 168, 216, | 83 |
| 165 | 2-Chloro-9-[3-(dimethylamino)-propylidene]thioxanthene (cis-form) and its salts | 182 | 84 |
| 166 | Chloroethane | 328 | 96 |
| 167 | Chloroform | 737 | 366 |
| 168 | 2-Chloro-6-methylpyrimidin-4-yldimethylamine | 164, 216 | 83 |
| 169 | Chlorophacinone (ISO) | 175 | 93 |
| 170 | 1-(p-Chloro-α-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine | 402 | 240 |
| 171 | 2-(4-Chlorophenyl)-1-[4-2-diethyl-aminoethoxyl)]phenyl-1-p-tolyethanol | 747 | 92 |
| 172 | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | 369 | 185 |
| 173 | 2-(4-Chlorophenyl)-3-methylbutane-2,3-diol | 554 | 95 |
| 174 | 2-(4-Chlorophenyl-3-methyl-1,3-thiazinan-4-one 1,1-dioxide | 160 | 91 |
| 175 | 2-[2-(4-Chlorophenyl)-2-phenylacetyl]indane-1,3-dione | 169 | 93 |
| 176 | 2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl-(dimethyl)amine | 179 | 94 |
| 177 | Chloropicrin | 738 | 325 |
| 178 | 3-(4-Chloro-3-sulphamoylphenyl)-3-hydroxyisoindolin-1-one | 183, 184 | 262 |
| 179 | Chlorphenoxamine (INN) | 176 | 94 |
| 180 | Chlorpromazine (INN) | (561) | 320 |
| 181 | Chlorpropamide (INN) | 617 | 79 |
| 182 | Chlorprohixene (INN) and its salts | 165 | 84 |
| 183 | Chlortalidone (INN) | 178, 184 | 262 |
| 184 | Chlorthalidone | 178, 184 | 262 |
| 185 | Chlorzoxazone (INN) | 162 | 82 |
| 186 | Cholecalciferol | (761) | 335 |
| 187 | Choline salts and their esters | — | 168 |
| 188 | Chromium, chromic acid and salts of the acid | — | 97 |
| 189 | Chrysoidine citrate hydrochloride | 565 | 81 |
| 190 | Cinchocaine (INN) and its salts | 126 | 129 |
| 191 | Cincophen (INN), its salts and derivatives and salts of those derivatives | 580 | 8 |
| 192 | Claviceps purpurea Tul., its alkaloids and galenical preparations | 318 | 98 |
| 193 | Clofenamide (INN) | 161 | 85 |
| 194 | Clofenotane (INN) | 734 | 123 |
| 195 | Coal tar, crude and refined | 218 | 420 |
| 196 | Cobalt benzenesulphonate | — | 101 |
| 197 | Cocculin | 592 | 282 |
| 198 | Colchicine, its salts and derivatives | — | 102 |
| 199 | Colchicoside and its derivatives | — | 103 |
| 200 | Colchicum automnale L, and its galenical preparations | — | 104 |
| 201 | Colouring agent CI 12075 and its lakes, pigments and salts | — | 397 |
| 202 | Colouring agent CI 12140 | — | 378 |
| 203 | Colouring agent CI 13065 | — | 387 |
| 204 | Colouring agent CI 15585 | — | 401 |
| 205 | Colouring agent CI 26105 | — | 379 |
| 206 | Colouring agent CI 42535 | — | 388 |
| 207 | Colouring agents CI 42555, 42555:1 and 42555:2 | — | 380 |
| 208 | Colouring agent CI 42640 | — | 386 |
| 209 | Colouring agent CI 45170 and CI 45170:1 | — | 398 |
| 210 | Colouring agent CI 61554 | — | 389 |
| 211 | Coniferyl benzoate (except natural content of essences) | 87 | 357 |
| 212 | Coniine | 618 | 290 |
| 213 | Conium maculatum L. (fruit, powder, galenical preparations) | — | 99 |
| 214 | Convallatoxin | — | 105 |
| 215 | Coumetarol (INN) | 454 | 225 |
| 216 | Crimidine (ISO) | 164, 168 | 83 |
| 217 | Croton tiglium (oil) | — | 107 |
| 218 | Crude and refined coal tars | 195 | 420 |
| 219 | Curare and curarine | — | 109 |
| 220 | Curarizants, synthetic | — | 110 |
| 221 | 1-(3-Cyano-3,3-diphenylpropyl)-4-ethoxycarbonyl-4-phenylpiperidinium chloride | 297 | 80 |
| 222 | Cyclarbamate (INN) | 230 | 122 |
| 223 | Cyclizine (INN) and its salts | 302 | 159 |
| 224 | Cyclobarbitone and its salts | (69) | 220 |
| 225 | Cyclocoumarol | 268 | 234 |
| 226 | 2-a-Cyclohexylbenzyl(N,N,N’,N’-tetraethyl)trimethylenediamine | 555 | 112 |
| 227 | 2-Cyclohexyl-3,5-dimethylphenol and its salts | 229 | 113 |
| 228 | Cyclohexyl-3-(p-methylbenzenesulphonyl)urea | 364 | 100 |
| 229 | Cyclomenol (INN) and its salts | 227 | 113 |
| 230 | Cyclopentane-1,1-dimethanol dicarbanilate | 222 | 122 |
| 231 | Cyclophosphamide (INN) and its salts | 103, 106 | 88 |
| 232 | Datura stranibuyn L. and its galenical preparations | 54 | 301 |
| 233 | DDT (ISO) (pp’-DDT) | 194 734 | 123 |
| 234 | Deanol aceglumate (INN) | 279 | 3 |
| 235 | Decamethonuium bromide (INN) | (236) | 214 |
| 236 | Decamethylene-bis(trimethylammonium) salts | 235 | 214 |
| 237 | Dextromethorphan (INN) and its salts | 457 | 226 |
| 238 | Dextropropoxyphene (INN) | 281 | 116 |
| 239 | O,O’-Diacetyl-N-allyl-N-normorphine | — | 117 |
| 240 | 2,4-Diaminoanisole and its salts | 455, 461 | 376 |
| 241 | 2,5-Diaminoanisole and its salts | 456, 460 | 377 |
| 242 | 1,2-Diaminobenzene and its salts | 573 | 363 |
| 243 | p,p’-Diaminodiphenyl | 82 | 26 |
| 244 | 2-(2,4-Diaminophenyl)ethanol and its salts | — | 407 |
| 245 | 1,4:3,6-Dianhydrosorbitol 2,5-dinitrate | 422 | 148 |
| 246 | 5-(α,β-Dibromophenethyl)-5-methylhydantoin | — | 119 |
| 247 | Dibromosalicylanilides | 248, 443 | 351 |
| 248 | Dibromsalan (INN) | (247) | 351 |
| 249 | Dichloroethanes | 330, 335 | 125 |
| 250 | Dichloroethylenes | 7, 759 | 126 |
| 251 | 2,3-Dichloro-2-methylbutane | 46 | 36 |
| 252 | Dichlorosalicylanilides | — | 349 |
| 253 | Dicoumarin | 254, 469 | 231 |
| 254 | Dicoumarol (INN) | 253, 469 | 231 |
| 255 | Diethanolamine | (108, 643) | 411 |
| 256 | 2-Diethylaminoethoxy)ethyl α-phenylpiperidine-1-acetate dimethiodide | 601 | 137 |
| 257 | 2-Diethylaminoethyl 3-amino-4-butoxybenzoate and its salts | 99 | 23 |
| 258 | 2-Diethylaminoethyl benzilate | 72 | 157 |
| 259 | 2-Diethylaminoethyl 4-ethoxybenzoate and its salts | 411, 538 | 179 |
| 260 | 2-Diethylaminoethyl 3-hydroxy-4-phenylbenzoate and its salts | — | 128 |
| 261 | 2-Diethylaminoethyl phenyl(piperidino)acetate | 101 | 287 |
| 262 | 3-Diethylaminopropyl cinnamate | — | 130 |
| 263 | Diethyl 4-nitrophenyl phosphate | 536 | 170 |
| 264 | O,O-Diethyl O-4-nitrophenyl phosphorothioate | 537 | 131 |
| 265 | Difencloxazine INN) | 569 | 270 |
| 266 | Digitaline and all heterosides of Digitalis purpureaL. | — | 134 |
| 267 | 4.5-Dihydrobenzimidazol-4-one | 85 86 | 48 |
| 268 | 3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano[3,2-c]-[1]]-benzopyran-5-one | 225 | 234 |
| 269 | Dihydrotachacysterol (INN) | – | 342 |
| 270 | 3,4-Dihydroxy-α-(methylaminomethyl)benzyl alcohol | 14, 315 | 14 |
| 271 | 4,4’-Dihydroxy-3,3’-(3-methylthiopropylideneI)dicoumarin | – | 207 |
| 272 | 1-(3,4-Dihydroxyphenyl)-2-ethylaminopropan-1-ol and its salts | 294 | 136 |
| 273 | 1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol | 418, 421 | 17 |
| 274 | Diisopropanolamine | (108, 643) | 411 |
| 275 | 5,5’-Di-isopropyl-2,2’-dimethylbiphenyl-4,4’-diyldihypoiodite | 413 | 361 |
| 276 | Dimethoxane | 286 | 368 |
| 277 | 4-[2-(3,4-Dimethoxyphenyl)ethyl]-1-(2-chlorophenyl)piperazine and its salts | 438 | 141 |
| 278 | Dimethylamine | — | 142 |
| 279 | 2-Dimethylaminoethyl N-acetylglutamate | 234 | 3 |
| 280 | 2-Dimethylaminoethyl p-butylaminobenzoate and its salts | 690 | 63 |
| 281 | (+)-4-Dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane | 238 | 116 |
| 282 | 1-Dimethylaminomethyl-1-methylpropyl benzoate and its salts | 50 | 50 |
| 283 | 2-Dimethylaminopropiophenone and its salts | 445 | 145 |
| 284 | 3-(3-Dimethylaminopropylidene)-1,2,4,5-dibenzocyclohepta-1,4-diene and its salts | 42 | 146 |
| 285 | 1,1-Dimethylbiguanide and its salts | 447 | 147 |
| 286 | 2,6-Dimethyl-1,3-dioxan-4-yl- acetate | 276 | 368 |
| 287 | Dimethylformamide | – | 355 |
| 288 | 1,5-Dimethylhexylamine and its salts | 34, 525 | 28 |
| 289 | 1,3-Dimethylpentylamine and its salts | 35, 471 | 30 |
| 290 | Dimethyl sulfoxide (INN) | — | 338 |
| 291 | Dimevamide (INN) and its salts | 298 | 153 |
| 292 | Dinitrophenol isomers | — | 151 |
| 293 | Dioxane | — | 343 |
| 294 | Dioxethedrin (INN) and its salts | 272 | 136 |
| 295 | 2,5-Dioxo-3,3-diethyl-5-methylpiperidine and its salts | 483 | 133 |
| 296 | Diphenhydramine (INN) and its salts | 81 | 339 |
| 297 | Diphenoxylate hydrochloride (INNM) | 221 | 80 |
| 298 | 2,2-Diphenyl-4-dimethylaminovaleramide and its salts | 291 | 153 |
| 299 | 5,5-Diphenyl-4-imidazolidone | — | 160 |
| 300 | 4-Diphenylmethoxy-1-methylpiperidine and its salts | 306 | 154 |
| 301 | 3-Diphenylmethoxytropane and its salts | 76 | 158 |
| 302 | 1-Diphenylmethyl-4-methylpiperazine and its salts | 223 | 159 |
| 303 | 1,2-Diphenyl-4-(2-phenylsulphinylethyl)-pyrazolidine-3,5-dione | 664 | 155 |
| 304 | α,α-Diphenyl-2-piperidinemethanol and its salts | 600 | 285 |
| 305 | α,α-Diphenyl-4-piperidinemethanol and its salts | 66 | 286 |
| 306 | Diphenylpyraline (INN) and its salts | 300 | 154 |
| 307 | 2,5-Dipropoxy-3,6-bis(ethyleneimino)-1,4-benzoquinone | 410 | 152 |
| 308 | 4-Dipropylsulphamoylbenzoic acid | 609 | 161 |
| 309 | Disulfiram (INN) | 702, 713 | 162 |
| 310 | Dithio-2,2’-bis(pyridine 1-oxide) 1,1’ (additive with trihydrated magnesium sulphate) | 628 | 396 |
| 311 | Doxylamine (INN) and its salts | 579 | 176 |
| 312 | Emetine, its salts and derivatives | — | 163 |
| 313 | Endrin (ISO) | 373 | 196 |
| 314 | Ephedrine and its salts | — | 164 |
| 315 | Epinephrine (INN) | 14, 270 | 14 |
| 316 | 1,2-Epoxybutane | — | 400 |
| 317 | Ergocalciferol (INN) | 138 (761) | 335 |
| 318 | Ergot and its alkaloids | 192 | 98 |
| 319 | Eserine and its salts | 589 | 166 |
| 320 | Ethionamide (INN) | 336 | 319 |
| 321 | Ethoheptazine (INN) and its salts | 476 | 173 |
| 322 | Ethopropazine and its salts | (561) | 320 |
| 323 | 4-Ethoxyphenol | (391) | 178 |
| 324 | 4-Ethoxy-m-phenylenediamine and its salts | — | 406 |
| 325 | 2-Ethylamino-5-phenyloxazolin-4-one | 345 | 180 |
| 326 | Ethyl bis(4-hydroxycoumarinyl)acetate and salts of the acid | 327 | 204 |
| 327 | Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid | 326 | 204 |
| 328 | Ethyl chloride | 166 | 96 |
| 329 | Ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate and its salts | 446 | 171 |
| 330 | Ethylene dichloride | (249) | 125 |
| 331 | Ethylene oxide | — | 182 |
| 332 | 2-Ethyl-2,3-epoxyhexamide and its derivatives | 530 | 165 |
| 333 | Ethyl p-fluorophenyl sulphone | 348 | 189 |
| 334 | Ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate and its salts | 532 | 172 |
| 335 | Ethylidene dichloride | (249) | 125 |
| 336 | 3-Ethylisothionicotinamide | 320 | 319 |
| 337 | 3-Ethyl-3-methylglutarimide and its salts | 71, 338 | 183 |
| 338 | 4-Ethyl-4-methylpiperidine-2,6-dione and its salts | 71, 337 | 183 |
| 339 | 2-Ethyl-3-methylvaleramide | 755 | 184 |
| 340 | Ethylphenacemide | 556, 568 | 272 |
| 341 | 2-Ethyl-2-phenylglutarimide and its salts | 362 | 181 |
| 342 | 3’-Ethyl-5’,6’,7’,8’-tetrahydro-5’,5’,8’,8’-tetramethyl-2’-acetonaphthone | 9 | 362 |
| 343 | Ethyl urocanate | (406) | 418 |
| 344 | Fenadiazole (INN) | 528 | 208 |
| 345 | Fenozolone (INN) | 325 | 180 |
| 346 | Fenyramidol (INN) | 578, 582 | 274 |
| 347 | Fluanisone (INN) | 351 | 187 |
| 348 | Fluoresone (INN) | 333 | 189 |
| 349 | 4’-Fluoro-4-[4-hydroxy-4-(α,α,α-trifluoro-m-tolyl)piperino]butyrophenone | 741 | 188 |
| 350 | 6-Fluoro-16-methyl-11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione | 535 | 186 |
| 351 | 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]butan-1-one | 347 | 187 |
| 352 | 5-Fluoropyrimidine-2,4-dione | 353 | 190 |
| 353 | Fluorouracil (INN) | 352 | 190 |
| 354 | Fluphenazine (INN) | (561) | 320 |
| 355 | Furazolidone (INN) | 513 | 252 |
| 356 | Furfuryltrimethylammonium salts | 358 | 192 |
| 357 | Furocoumarins (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | 96, 462, 623, 746 | 358 |
| 358 | Furtrethonium iodide (INN) | (356) | 192 |
| 359 | Galantamine (INN) | — | 193 |
| 360 | Gallamine triethiodide (INN) | 518 | 329 |
| 361 | Glucocorticoids | 98 | 300 |
| 362 | Glutethimide (INN) and its salts | 341 | 181 |
| 363 | Glycerol trinitrate | 514, 615 | 253 |
| 364 | Glycyclamide (INN) | 228 | 100 |
| 365 | Gold salts | — | 296 |
| 366 | Guaifenesin (INN) | 459 | 230 |
| 367 | Guanethidine (INN) and its salts | 368 | 259 |
| 368 | N-(2-Guanidinoethyl)azocane and its salts | 367 | 259 |
| 369 | Haloperidol (INN) | 172 | 185 |
| 370 | HCH (ISO) (gamma-HCH) | 100, 372, 428 | 195 |
| 371 | HETP | 378 | 316 |
| 372 | 1,2,3,4,5,6-Hexachlorocyclohexane | 100, 370, 428 | 195 |
| 373 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8 dimethanonaphthalene | 313 | 196 |
| 374 | Hexachloroethane | — | 197 |
| 375 | 3,3’4,4’6,6’-Hexachloro-2,2’-methylenediphenol | 376 | 371 |
| 376 | Hexachlorophene (INN) | 375 | 371 |
| 377 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene | 416 | 198 |
| 378 | Hexaethyl tetraphosphate | 371 | 316 |
| 379 | (1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride | 140 | 70 |
| 380 | (3S,5aR,9bS)-3,3a,4,5,5a,9b-Hexahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8-dione | 639 | 217 |
| 381 | Hexamethonium bromide (INN) | (382) | 124 |
| 382 | N-N’-Hexamethylenebis(trimethylammonium) salts | 381 | 124 |
| 383 | Hexapropymate (INN) | 619 | 115 |
| 384 | Hydrastine, hydrastinine and their salts | — | 199 |
| 385 | Hydrazides and their salts | — | 200 |
| 386 | Hydrazine, its derivatives and their salts | — | 201 |
| 387 | 2-Hydrazino-octane and its salts | 523 | 202 |
| 388 | Hydrocyanic acid and its salts | 390, 409, 604 | 111 |
| 389 | Hydrofluoric acid, its normal salts, complexes and hydrofluorides (except those listed in Part I of Schedule 4) | — | 191 |
| 390 | Hydrogen cyanide and its salts | 388, 409, 604 | 111 |
| 391 | Hydroquinone monobenzyl and monoethyl ethers | 487 | 178 |
| 392 | 7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline | 764 | 135 |
| 393 | [4-[4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl] acetic acid and its salts | 742 | 5 |
| 394 | 3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propionic acid and its salts | 716 | 9 |
| 395 | 2-Hydroxy-3-(2-methoxyphenyl)propyl carbamate | 450 | 205 |
| 396 | 1-Hydroxymethyl-1-cyclohexcylacetic acid, sodium salt | 646 | 114 |
| 397 | 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]coumarin | 1 | 254 |
| 398 | 8-Hydroxy-5-nitroquinoline and its salts | 517 | 209 |
| 399 | 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin and its salts | 3, 762 | 203 |
| 400 | 11α-Hydroxypregn-4-ene-3,20-dione and its esters | — | 385 |
| 401 | Hydroxy-8-quinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 4 | 112, 533, 633 | 395 |
| 402 | Hydroxyzine (INN) | 170 | 240 |
| 403 | Hyoscine, its salts and derivatives | 641 | 295 |
| 404 | Hyoscyamine, its salts and derivatives | — | 210 |
| 405 | Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations) | — | 211 |
| 406 | 3-Imidazol-4-ylacrylic acid and its ethyl ester | 343, 753 | 418 |
| 407 | 2-Imino-5-phenyloxazolidin-4-one and its salts | 540 | 212 |
| 408 | Imperatorin | 465 | 34 |
| 409 | Inorganic cyanides | (388, 390), 604 | 111 |
| 410 | Inproquone (INN) | 307 | 152 |
| 411 | Intracaine and its salts | 259, 538 | 179 |
| 412 | Iodine | — | 213 |
| 413 | Iodothymol | 275 | 361 |
| 414 | Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations) | — | 215 |
| 415 | Isocarboxazid (INN) | 91 | 52 |
| 416 | Isodrin | 377 | 198 |
| 417 | Isometheptene (INN) and its salts | 463 | 228 |
| 418 | Isoprenaline (INN) | 273, 421 | 17 |
| 419 | Isopropamide iodide (INN) | (144) | 156 |
| 420 | (2-Isopropylpent-4-enoyl)urea | 60 | 216 |
| 421 | Isoproterenol | 273, 418 | 17 |
| 422 | Isosorbide dinitrate (INN) | 245 | 148 |
| 423 | Juniperus Sabina L (leaves, essential oil and galenical preparations) | — | 294 |
| 424 | Laurus nobilis L. (oil from seeds) | — | 359 |
| 425 | Lead and its compounds (except lead acetate subject to the restrictions laid down in entry number 55 in Part I of Schedule 4) | — | 289 |
| 426 | Levophacetoperane and its salts | 597 | 284 |
| 427 | Lidocaine (INN) (Lignocaine) | — | 399 |
| 428 | Lindane | 100, 370, 372 | 195 |
| 429 | Lobelia inflata L. and its galenical preparations | — | 218 |
| 430 | Lobeline (INN) and its salts | 110 | 219 |
| 431 | LSD | (433 434) | 127 |
| 432 | Lupinidine and its salts | 651 | 299 |
| 433 | Lysergic acid diethylamide and its salts | 431, 434 | 127 |
| 434 | Lysergide (INN) and its salts | 431, 433 | 127 |
| 435 | Malononitrile | — | 149 |
| 436 | Mannomustine (INN) and its salts | 102 | 89 |
| 437 | Mecamylamine (INN) | 701 | 229 |
| 438 | Mefeclorazine (INN) and its salts | 277 | 141 |
| 439 | Mephenesin (INN) and its esters | 721 | 322 |
| 440 | Meprobamate (INN) | 481 | 236 |
| 441 | Mercury and its compounds (except those listed in Part I of Schedule 6) | — | 221 |
| 442 | Mescaline and its salts | 743 | 222 |
| 443 | Metabromsalan (INN) | (247) | 351 |
| 444 | Metaldehyde | 603 | 223 |
| 445 | Metamfepramone (INN) and its salts | 283 | 145 |
| 446 | Metethoheptazine (INN) and its salts | 329 | 171 |
| 447 | Metformin (INN) and its salts | 285 | 147 |
| 448 | Methapyrilene (INN) and its salts | 627 | 144 |
| 449 | Metheptazine (INN) and its salts | 468 | 174 |
| 450 | Methocarbamol (INN) | 395 | 205 |
| 451 | Methohexitone and its salts | (69) | 220 |
| 452 | Methotrexate (INN) | 33 | 6 |
| 453 | 2-[4-Methoxybenzyl-N-(2-pyridyl)amino]-ethyldimethylamine maleate | 625 | 346 |
| 454 | 1-Methoxy-2,2-bis(4-hydroxy-3-coumarinyl)ethane | 215 | 225 |
| 455 | 1-Methoxy-2,4-diaminobenzene and its salts | 240, 461 | 376 |
| 456 | 1-Methoxy-2,5-diaminobenzene and its salts | 241, 460 | 377 |
| 457 | (+)-3-Methoxy-N-methylmorphinan and its salts | 237 | 226 |
| 458 | ENTRY DELETED | ||
| 459 | 3-(2-Methoxyphenoxy)propane-1,2-diol | 366 | 230 |
| 460 | 2-Methoxy-p-phenylenediamine and its salts | 241, 456 | 377 |
| 461 | 4-Methoxy-m-phenylenediamine and its salts | 240, 455 | 376 |
| 462 | Methoxypsoralens (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (357) | 358 |
| 463 | 6-Methylamino-2-methylhept-2-ene and its salts | 417 | 228 |
| 464 | 2-Methyl-1,2-bis(3-pyridyl)propan-1-one | 484 | 292 |
| 465 | 9-(3-Methylbut-2-enyloxy)furo-[3,2-g]chromen-7-one | 408 | 34 |
| 466 | 2-Methyl-6-chloroanilide of n-butylaminoacetic acid and its salts | 123 | 90 |
| 467 | 1-Methyl-2,4-diaminobenzene and its salts | 477 | 364 |
| 468 | Methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate and its salts | 449 | 174 |
| 469 | 3,3-Methylenebis-(4-hydroxycoumarin) | 253, 254 | 231 |
| 470 | 2-Methylheptylamine and its salts | — | 227 |
| 471 | 4-Methyl-2-hexylamine and its salts | 35, 289 | 30 |
| 472 | 1-Methylimidazole-2-thiol | 474, 707 | 233 |
| 473 | N,N’ [Methylimino)diethylene]bis-(ethyldimethylammonium) salts | 67 | 121 |
| 474 | 1-Methyl-2-mercaptoimidazole | 472, 707 | 233 |
| 475 | Methylphenidate (INN) and its salts | 575 | 175 |
| 476 | 1-Methyl-4-phenyl-4-carbethoxyhexa-methyleneimine and its salts | 321 | 173 |
| 477 | 4-Methyl-m-phenylenediamine and its salts | 467 | 364 |
| 478 | 2-Methyl-m-phenylenediamine | — | 413 |
| 479 | 3-Methyl-2-phenylmorpholine, its derivatives and salts | 558 | 232 |
| 480 | 2-Methyl-2-propyl-1-isopropylcarbamoyloxy-3-carbamoyloxypropane | 150 | 235 |
| 481 | 2-Methyl-2-propyltrimethylene dicarbamate | 440 | 236 |
| 482 | N-Methyl-1,2,5,6-tetrahydro-3-nicotine acid methyl ester | 61 | 238 |
| 483 | Methyprylon (INN) and its salts | 295 | 133 |
| 484 | Metyrapone (INN) | 464 | 292 |
| 485 | Minoxidil (INN), its salts and derivatives | 599 | 372 |
| 486 | Mofebutazone (INN) | 131 | 64 |
| 487 | Monobenzone (INN) | 94, (391) | 178 |
| 488 | Morpholine and its salts | — | 344 |
| 489 | Moskene | 546 | 421 |
| 490 | Musk ambrette | 130 | 414 |
| 491 | Musk tibetene | 135 | 422 |
| 492 | Mustine and its salts | 104, 159 | 87 |
| 493 | Mustine N-oxide and its salts | 105 | 86 |
| 494 | Nalorphine (INN), its salts and ethers | 21 | 20 |
| 495 | Naphazoline (INN) and its salts | 501 | 244 |
| 496 | 2-Naphthol | 497 | 241 |
| 497 | β-Naphthol | 496 | 241 |
| 498 | 1-and 2-Naphthylamines and their salts | 499 | 242 |
| 499 | α-and β-Naphthylamines and their salts | 498 | 242 |
| 500 | 3-(1-Naphthyl)-4-hydroxycoumarin | — | 243 |
| 501 | 2-(1-Naphthylmethyl)-2-imidazoline and its salts | 495 | 244 |
| 502 | Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on Narcotic Drugs 1961 (Treaty Series No. 34 (1965), Cmnd. 2631) | — | 306 |
| 503 | Narcotine and its salts | 521 | 258 |
| 504 | Neodymium and its salts | — | 309 |
| 505 | Neostigmine and its salts | — | 245 |
| 506 | Nicotine and its salts | — | 246 |
| 507 | Nitrites, inorganic (except sodium nitrite) | — | 248 |
| 508 | Nitrobenzene | — | 249 |
| 509 | Nitrocresols and their alkali metal salts | — | 250 |
| 510 | Nitroderivatives of carbazole | 145 | 72 |
| 511 | Nitrofurantoin (INN) | 512 | 251 |
| 512 | N-(5-Nitro-2-furfurylidene)-1-aminohydantoin | 511 | 251 |
| 513 | 3-(5-Nitrofurfurylideneamino)oxazolidin-2-one | 355 | 252 |
| 514 | Nitroglycerine | 363, 615 | 253 |
| 515 | Nitrosamines | — | 410 |
| 516 | Nitrostilbenes, their homologues and derivatives | — | 256 |
| 517 | Nitroxoline (INN) and its salts | 398 | 209 |
| 518 | N,N,N,N’,N’,N”,N”,N”-Nonaethyl-2,2’2”-(benzene-1,2,3-triyltrioxy)-tris(ethanaminium) triiodide | 360 | 329 |
| 519 | Noradrenaline and its salts | 32, 520 | 257 |
| 520 | Norepinephrine (INN) and its salts | 32, 519 | 257 |
| 521 | Noscapine (INN) and its salts | 503 | 258 |
| 522 | Nux Vomica and its preparations | (661) | 305 |
| 523 | Octamoxin (INN) and its salts | 387 | 202 |
| 524 | Octamylamine (INN) and its salts | — | 267 |
| 525 | Octodrine (INN) and its salts | 34, 288 | 28 |
| 526 | Oestrogens | — | 260 |
| 527 | Oleandrin | — | 261 |
| 528 | 2-(1,3,4-Oxadiazol-2-yl)phenol | 344 | 208 |
| 529 | [Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts | 24 | 132 |
| 530 | Oxanamide (INN) and its derivatives | 332 | 165 |
| 531 | 2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11b-H-benzo[a]quinolizine and its salts | 688 | 139 |
| 532 | Oxpheneridine (INN) and its salts | 334 | 172 |
| 533 | Oxyquinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 4 | 112, 401, 633 | 395 |
| 534 | Padimate A | 47 | 381 |
| 535 | Paramethasone (INN) | 350 | 186 |
| 536 | Paraoxon | 263 | 170 |
| 537 | Parathion (ISO) | 264 | 131 |
| 538 | Parethoxycaine (INN) and its salts | 259, 411 | 179 |
| 539 | Pelletierine and its salts | 598 | 263 |
| 540 | Pemoline (INN) and its salts | 407 | 212 |
| 541 | Pentachloroethane | — | 264 |
| 542 | Pentaerythritol chloral | 552 | 266 |
| 543 | Pentaerythritol tetranitrate | 544, 551 | 265 |
| 544 | Pentaerythrityl tetranitrate (INN) | 543, 551 | 265 |
| 545 | Pentamethonium bromide (INN) | (547) | 120 |
| 546 | 1,1,3,3,5-Pentamethyl-4,6-dinitroindane | 489 | 421 |
| 547 | N,N’-Pentamethylenebis(trimethylammonium) salts | 545 | 120 |
| 548 | Pentobarbitone and its salts | (69) | 220 |
| 549 | Perchloroethylene | 692 | 314 |
| 550 | Perphenazine (INN) and its salts | (561) | 320 |
| 551 | PETN | 543, 544 | 265 |
| 552 | Petrichloral (INN) | 542 | 266 |
| 553 | Phenacemide (INN) | 564 | 269 |
| 554 | Phenaglycodol (INN) | 173 | 95 |
| 555 | Phenetamine | 226 | 112 |
| 556 | Pheneturide (INN) | 340, 568 | 272 |
| 557 | Phenindone (INN) | 574 | 271 |
| 558 | Phenmetrazine (INN), its derivatives and salts | 479 | 232 |
| 559 | Phenobarbitone and its salts | (69) | 220 |
| 560 | Phenolphthalein (INN) | 111 | 417 |
| 561 | Phenothiazine (INN) and its compounds | various | 320 |
| 562 | Phenprobamate (INN) | 576 | 71 |
| 563 | Phenprocoumon (INN) | 577 | 273 |
| 564 | N-Phenylacetylurea | 553 | 269 |
| 565 | 4-Phenylazophenylene-1,3-diamine citrate hydrochloride | 189 | 81 |
| 566 | Phenylbutazone (INN) | 129 | 67 |
| 567 | 4-Phenylbut-3-en-2-one | 92 | 356 |
| 568 | (2-Phenylbutyryl)urea | 340, 556 | 272 |
| 569 | N-[2-(α-Phenyl-p-chlorobenzyl)ethyl]morpholine | 265 | 270 |
| 570 | 1-Phenylcyclopentanecarboxylic acid diethylaminoethyl ester and its salts | 143 | 169 |
| 571 | 2-Phenycyclopropylamine (trans-form) and its salts | 722 | 324 |
| 572 | 1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one | 620 | 138 |
| 573 | o-Phenylenediamine and its salts | 242 | 363 |
| 574 | 2-Phenylindan-1,3-dione | 557 | 271 |
| 575 | α-Phenyl-2-piperidineacetic acid methyl ester and its salts | 475 | 175 |
| 576 | 3-Phenylpropyl carbamate | 562 | 71 |
| 577 | 3-(α-Phenylpropyl)-4-hydroxycoumarin | 563 | 273 |
| 578 | 1-Phenyl-2-(2-pyridylamino)ethanol | 346, 582 | 274 |
| 579 | 2-[1-Phenyl-1-(2-pyridyl)ethoxy]-ethyldimethylamine and its salts | 311 | 176 |
| 580 | 2-Phenylquinoline-4-carboxylic acid its salts and derivatives and salts of those derivatives | 191 | 8 |
| 581 | 6-Phenyl-2,4,7-triaminopteridine and its salts | 725 | 275 |
| 582 | Phenyramidol | 346, 578 | 274 |
| 583 | Phosphides, metal | — | 279 |
| 584 | Phosphorus | — | 279 |
| 585 | 4-Phosphoryloxy-N,N-dimethyltryptamine | 622 | 278 |
| 586 | 3-Phthalimidopiperidine-2,6-dione and its salts | 704 | 280 |
| 587 | Phthalylsulphathiazole (INN) and its salts | (678) | 307 |
| 588 | Physostigma veneriosum Balf. | 137 | 281 |
| 589 | Physostigmine and its salts | 319 | 166 |
| 590 | Phytolacca spp and their preparations | — | 374 |
| 591 | Picric acid | 745 | 268 |
| 592 | Picrotoxin | 197 | 282 |
| 593 | Pilocarpine and its salts | — | 283 |
| 594 | Pilocarpus jaborandi Holmes and its galenical preparations | — | 311 |
| 595 | Pipazetate (INN) and its salts | 596 | 118 |
| 596 | 2-(2-Piperidinoethoxy)ethyl 10-thia-1,9-diazaanthracene-9-carboxylate and its salts | 95 | 118 |
| 597 | α-Piperidin-2-ylbenzyl acetate laevorotatory threo-form and its salts | 426 | 284 |
| 598 | 1-(2-Piperidyl)propan-2-one and its salts | 539 | 263 |
| 599 | 6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide, its salts and derivatives | 485 | 372 |
| 600 | Pipradrol (INN) and its salts | 304 | 285 |
| 601 | Piprocurarium idodide (INN) | 256 | 137 |
| 602 | Poldine metilsulfate (INN) (Poldine methylsulphate) | 84 | 239 |
| 603 | Polyacetaldehyde | 444 | 223 |
| 604 | Potassium cyanide | (388, 390, 409) | 111 |
| 605 | Potassium nitroferricyanide | (15), 606 | 255 |
| 606 | Potassium nitroprusside | (15), 605 | 255 |
| 607 | Pramocaine (INN) | 608 | 405 |
| 608 | Pramoxine | 607 | 405 |
| 609 | Probenecid (INN) | 308 | 161 |
| 610 | Procainamide (INN) its salts and derivatives | 29 | 25 |
| 611 | Prochlorperazine (INN) and its salts | (561) | 320 |
| 612 | Progestogens | — | 194 |
| 613 | Promazine (INN) and its salts | (561) | 320 |
| 614 | Promethazine (INN) and its salts | (561) | 320 |
| 615 | Propane-1’,2,3-triyl trinitrate | 363, 514 | 253 |
| 616 | Propatylnitrate (INN) | 109 | 206 |
| 617 | 1-Propyl-3-(4-chlorobenzenesulphonyl)urea | 181 | 79 |
| 618 | 2-Propylpiperidine | 212 | 290 |
| 619 | 1-(2-Propynyl)cyclohexyl carbamate | 383 | 115 |
| 620 | Propyphenazone(INN) | 572 | 138 |
| 621 | Prunus laurocerasus L. | 156 | 291 |
| 622 | Psilocybine (INN) | 585 | 278 |
| 623 | Psoralen (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (357) | 358 |
| 624 | Pyrethrum album L. and its galenical preparations | — | 345 |
| 625 | Pyrianisamine maleate | 453 | 346 |
| 626 | Pyribenzamine | 95, 748 | 347 |
| 627 | 2-(N-2-Pyridyl-N-2-thienylamino)ethyl-dimethylamine and its salts | 448 | 144 |
| 628 | Pyrithione disulphide + magnesium sulphate | 310 | 396 |
| 629 | Pyrithione sodium | — | 369 |
| 630 | Pyrocatechol | 79, 152 | 408 |
| 631 | Pyrogallol | 80 | 409 |
| 632 | Quinalbarbitone and its salts | (69) | 220 |
| 633 | Quinolin-8-ol (except for the uses provided for in entry number 51 in Part I of Schedule 4) | (401, 533) | 395 |
| 634 | Radioactive substances (within the meaning of Article 1 of Council Directive 96/29/Euratom(a) laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation) | — | 293 |
| 635 | Rauwlfia serpentine alkaloids and their salts | 636 | 15 |
| 636 | Reserpine (INN) and its salts | (635) | 15 |
| 637 | Retinoic acid and its salts | 724, 760 | 375 |
| 638 | Safrole (except natural content of essences in cases where the concentration of such safrole in the cosmetic product does not exceed— (a) in the case of oral hygiene or dental products other than toothpaste intended specifically for children, 50 mg/kg; or (b) in the case of products other than oral hygiene or dental products, 100 mg/kg) | — | 360 |
| 639 | α-Santonin | 380 | 214 |
| 640 | Schoenocaulon officinale Lind. (seeds and galenical preparations) | — | 332 |
| 641 | Scopolamine, its salts and derivatives | 403 | 295 |
| 642 | Secbutobarbitone and its salts | (69) | 220 |
| 643 | Secondary alkyl- and alkanolamines and their salts | 108, 255, 274 | 411 |
| 644 | Selenium and its compounds (except when permitted under the restrictions laid down in Part I of Schedule 4) | — | 297 |
| 645 | Sodium cyanide | (388, 390, 409) | 111 |
| 646 | Sodium hexacyclonate (INN) | 396 | 114 |
| 647 | Sodium nitroferricyanide | (15), 648 | 255 |
| 648 | Sodium nitroprusside | (15), 647 | 255 |
| 649 | Solanum nigrum L. and its galenical preparations | – | 298 |
| 650 | Spanish Fly | 139 | 69 |
| 651 | Sparteine (INN) and its salts | 432 | 299 |
| 652 | Spironolactone (INN) | 10 | 4 |
| 653 | Squill and its preparations | 752 | 330 |
| 654 | Stramonium and its preparations | 232 | 301 |
| 655 | Strontium lactate | - | 402 |
| 656 | Strontium nitrate | - | 403 |
| 657 | Strontium polycarboxylate | - | 404 |
| 658 | Strophanthines and their aglucones and their respective derivatives | - | 302 |
| 659 | Strophanthus species and their galenical preparations | - | 303 |
| 660 | Strychnine and its salts | - | 304 |
| 661 | Strychnos species and their galenical preparations | 522 | 305 |
| 662 | Succinonitrile | - | 150 |
| 663 | Succinylsulphathiazole and its salts | (678) | 307 |
| 664 | Sulfinpyrazone (INN) | 303 | 155 |
| 665 | Sulphacetamide and its salts | (678) | 307 |
| 666 | Sulphadiazine and its salts | (678) | 307 |
| 667 | Sulphadimethoxine and its salts | (678) | 307 |
| 668 | Sulphadimidine and its salts | (678) | 307 |
| 669 | Sulphafurazole and its salts | (678) | 307 |
| 670 | Sulphaguanidine and its salts | (678) | 307 |
| 671 | Sulphamethizole and its salts | (678) | 307 |
| 672 | Sulphamethoxazole and its salts | (678) | 307 |
| 673 | Sulphamethoxydiazine and its salts | (678) | 307 |
| 674 | Sulphamethoxypyridazine and its salts | (678) | 307 |
| 675 | Sulphanilamide and its salts | (678) | 307 |
| 676 | Sulphapyridine and its salts | (678) | 307 |
| 677 | Sulphathiazole and its salts | (678) | 307 |
| 678 | Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts | 665-677 | 307 |
| 679 | Sulthiame | 680, 699 | 308 |
| 680 | Sultiame (INN) | 679, 699 | 308 |
| 681 | Sympathomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe | 44 | 21 |
| 682 | Tefazoline (INN) and its salts | 698 | 237 |
| 683 | Tellurium and its compounds | - | 312 |
| 684 | TEPP (ISO) | 696 | 276 |
| 685 | 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline and its salts | 766 | 313 |
| 686 | 4-tert-Butylphenol | - | 340 |
| 687 | 4-tert-Butylpyrocatechol | - | 341 |
| 688 | Tetrabenazine (INN) and its salts | 531 | 139 |
| 689 | Tetrabromosalicylanilides | - | 367 |
| 690 | Tetracaine (INN) and its salts | 280 | 63 |
| 691 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin | - | 367 |
| 692 | Tetrachloroethylene | 549 | 314 |
| 693 | Tetrachloromethane | 147 | 315 |
| 694 | Tetrachlorosalicylanilides | - | 348 |
| 695 | Tetraethylammonium bromide | 703 | 61 |
| 696 | Tetraethyl pyrophosphate | 684 | 276 |
| 697 | (R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol and its salts | 59 | 42 |
| 698 | 2-(5,6,7,8-Tetrahydro-1-naphthylmethylmethyl)-2-imidazoline and its salts | 682 | 237 |
| 699 | 4-(Tetrahydro-2H-1,2-thiazin-2-yl)-benzenesulphonamide S,S-dioxide | 679, 680 | 308 |
| 700 | Tetrahydrozoline and its salts | - | 394 |
| 701 | N,2,3,3-Tetramethyl-2-nocamphanamine | 437 | 229 |
| 702 | Tetramethylthiuram disulphide | 713 | 162 |
| 703 | Tetrylammonium bromide (INN) | 695 | 61 |
| 704 | Thalidomide (INN) and its salts | 586 | 280 |
| 705 | Thallium and its compounds | - | 317 |
| 706 | Thevetia neriifolia Juss., glycoside extract | - | 318 |
| 707 | Thiamazole (INN) | 472, 474 | 233 |
| 708 | 2,2’-Thiobis(4,6-dichlorophenol) | 113 | 352 |
| 709 | Thiopentone and its salts | (69) | 220 |
| 710 | Thioridazine (INN) and its salts | (561) | 320 |
| 711 | Thiotepa (INN) | 726 | 310 |
| 712 | Thiourea and its derivatives (except those listed Part I of Schedule 4) | - | 321 |
| 713 | Thiram (ISO) | 702 | 162 |
| 714 | Thiuram disulphides | - | 354 |
| 715 | Thuiram monosulphides | - | 353 |
| 716 | Thyropropic acid (INN) and its salts | 394 | 9 |
| 717 | Tolboxane (INN) | 720 | 177 |
| 718 | Tolbutamide (INN) | 132 | 65 |
| 719 | Toluidines, their isomers, salts and halogenated and sulphonated derivatives | 40 | 32 |
| 720 | p-Tolyboric acid ester of 2-methyl-2-propylpropane-1,3-diol | 717 | 177 |
| 721 | 3-o-Tolyoxypropane-1,2-diol | (439) | 322 |
| 722 | Tranylcypromine (INN) and its salts | 571 | 324 |
| 723 | Tretamine (INN) | 727 | 328 |
| 724 | Tretinoin (INN) and its salts | 637, 760 | 375 |
| 725 | Triamterene (INN) and its salts | 581 | 275 |
| 726 | Tri(aziridin-1-yl)phosphine sulphide | 711 | 310 |
| 727 | 2,4,6-Tri(aziridin-l-yl)-1,3-triazine | 723 | 328 |
| 728 | 2,2,2-Tribromeothanol | (729) | 326 |
| 729 | Tribromoethyl alcohol | 728 | 326 |
| 730 | Tribromsalan (INN) | 731 | 373 |
| 731 | 3,4’,5-Tribromosalicylanilde | 730 | 373 |
| 732 | Trichlormethine (INN) and its salts | 749 | 327 |
| 733 | Trichloroacetic acid | - | 10 |
| 734 | 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane | 194, 233 | 123 |
| 735 | 2,2,2-Trichloroethane-1,1-diol | 157 | 77 |
| 736 | Trichloromethane | 167 | 366 |
| 737 | N-(Trichloromethylthio)cyclohex-4-ene-1,2-dicarboximide | 141 | 370 |
| 738 | Trichloronitromethane | 177 | 325 |
| 739 | Tricresyl phosphate | 750 | 277 |
| 740 | Trifluoperazine (INN) and its salts | (561) | 320 |
| 741 | Trifluperidol (INN) | 349 | 188 |
| 742 | 3,3’,5-Triiodothyroacetic acid and its salts | 393 | 5 |
| 743 | 3,4,5-Trimethoxyphenethylamine and its salts | 442 | 222 |
| 744 | 2.2,6-Trimethyl 1-4-piperidyl benzoate and its salts | 75 | 51 |
| 745 | 2,4,6-Trinitrophenol | 591 | 268 |
| 746 | Trioxysalen (INN) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (357) | 358 |
| 747 | Triparanol (INN) | 171 | 92 |
| 748 | Tripelennamine (INN) | 95, 626 | 347 |
| 749 | Tris(2-chloroethyl)amine | 732 | 327 |
| 750 | Tritolyl phosphate | 739 | 277 |
| 751 | Tauminoheptane (INN), its isomers and salts | 30 | 27 |
| 752 | Urginea scilla Stern. and its galenical preparations | 653 | 330 |
| 753 | Urocanic acid | (406) | 418 |
| 754 | Vaccines, toxins and serums listed in the Annex to Council Directive No. 75/319/EEC(a) | - | 323 |
| 755 | Valnoctamide (INN) | 339 | 184 |
| 756 | Veratrine, its salts and galenical preparations | - | 331 |
| 757 | Veratrun spp and their preparations | - | 333 |
| 758 | Vinyl chloride monomer | - | 334 |
| 759 | Vinylidene chloride | (7,250) | 126 |
| 760 | Vitamin A acid and its salts | 637, 724 | 375 |
| 761 | Vitamins D2 and D3 | 138, 186, 317 | 335 |
| 762 | Warfarin (ISO) and its salts | 3, 399 | 203 |
| 763 | Xanthates | 16 | 336 |
| 764 | Xanthinol | 392 | 135 |
| 765 | Xylidines, their isomers, salts and halogenated and sulphonated derivatives | 41 | 33 |
| 766 | Xylometazoline (INN) and its salts | 685 | 313 |
| 767 | Yohimbine and its salts | - | 337 |
| 768 | Zirconium and its compounds (except aluminium chloride hyroxide complexes and aluminium zirconium chloride hydroxide glycine complexes under the conditions laid down in Part I of Schedule 4 and zirconium lakes, salts and pigments prepared from those colouring agents identified in column 1 Part I of Schedule 5 by “*” immediately after the name or colour index number) | - | 391 |
| 769 | Zoxazolamine (INN) | 28 | 24 |
Regulation 5(2)
Commencement Information
I24Sch. 3 Pt. 2 in force at 11.9.2004, see reg. 1(1)
| (1) | (2) | (3) | (4) |
|---|---|---|---|
| Number in this Schedule | Name of substance | Cross-reference to this Schedule | Cross-reference to Annex II of the Directive |
| 1 | Alanroot oil (Inula helenium) | - | 423 |
| 2 | Benzyl cyanide | 31 | 424 |
| 3 | Cyclamen alcohol | 22 | 425 |
| 4 | Decahydro-6-isopropyl-2-naphthol | 21 | 441 |
| 5 | Diethyl maleate | - | 426 |
| 6 | Dihydrocoumarin | 8 | 427 |
| 7 | 6,7-Dihydrogeraniol | 10 | 429 |
| 8 | 3,4-Dihydroxycoumarin | 6 | 427 |
| 9 | 2,4-Dihydroxy-3-methylbenzaldehyde | - | 428 |
| 10 | 3,7-Dimethyl-2-octen-1-ol | 7 | 429 |
| 11 | 4,6-Dimethyl-8-tert-butylcoumarin | - | 430 |
| 12 | Dimethyl citraconate | - | 431 |
| 13 | 7,11-Dimethyl-4,6-10-dodecatrien-3-one | - | 432 |
| 14 | 6,10-Dimethyl-3,5,9-undecatrien-2-one | - | 433 |
| 15 | Diphenylamine | - | 434 |
| 16 | Ethyl acrylate | - | 435 |
| 17 | Fig leaf absolute (Ficus carica) | - | 436 |
| 18 | trans-2-Heptenal | - | 437 |
| 19 | trans-2-Hexenal diethyl acetal | - | 438 |
| 20 | trans-2-Hexenal dimethyl acetal | - | 439 |
| 21 | Hydroabietyl alcohol | - | 440 |
| 22 | 6-Isopropyl-2-decahydronaphthalenol | 4 | 441 |
| 23 | 3-(4-Isopropylphenyl)-2-methylpropan-1-ol | 3 | 425 |
| 24 | 7-Methoxycoumarin | - | 442 |
| 25 | 4-(4-Methoxyphenyl)-3-butene-2-one | - | 443 |
| 26 | 1-(4-Methoxyphenyl)-1-penten-3-one | - | 444 |
| 27 | Methyl trans-2-butenoate | - | 445 |
| 28 | 7-Methylcoumarin | - | 446 |
| 29 | Methyleugenol (except for normal content in the natural essences used, and provided that the concentration does not exceed: (a) 0.01 per cent in fine fragrance; (b) 0.004 per cent in eau de toilette; (c) 0.002 per cent in fragrance cream; (d) 0.001 per cent in rinse-off products; and (e) 0.0002 per cent in other leave-on products and oral hygiene products) | - | 451 |
| 30 | 5-Methyl-2,3-hexanedione | 447 | |
| 31 | 2-Pentylidenecyclohexanone | - | 448 |
| 32 | 2-Phenylacetonitrile | 2 | 424 |
| 33 | 3,6,10-Trimethyl-3,5,9-undecatrien-2-one | - | 449 |
| 34 | Verbena oil (Lippia citriodora Kunth.) | - | 450 |
Regulations 5(2), 6(1) and 7(2), 7(9)
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in columns 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used except for the purposes or contained other than in the types of product specified in column 3. The concentration of the substance in a product may not exceed the limit specified in column 4: where the names of two or more substances are mentioned in a single item as set out in column 2 and a product contains more than one of those substances, the limit specified in column 4 is the limit for all of those substances taken together; and where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 5. In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
Names which appear in square brackets in column 2 are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC(16).
Regulation 1(3) provides that until 24th March 2005 entries 14, 60, 61 and 62 shall be inserted into Part 1 of this Schedule as they appear in Part 1 of Schedule 4 to the Cosmetic (Products) (Safety) Regulations 2003(17). From 24th March 2005 the above entries shall have effect as they appear in Part 1 of this Schedule.
Regulation 1(4) provides that entries 93,94 and 95 in Part 1 of this Schedule shall not form part of this Schedule until 24th March 2005.
Commencement Information
I25Sch. 4 Pt. 1 in force at 11.9.2004 in so far as commenced by inducing regs. 5(2), 6(1), see reg. 1(1)
I26Sch. 4 Pt. 1 in force at 11.3.2005 in so far as commenced by inducing reg. 7(2)(9), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) | (6) |
|---|---|---|---|---|---|
| Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information |
| 1a | Boric acid, borates, and tetraborates‘ | Talcum power | 5 per cent | Not to be used in products intended for children under three years old Not to be used in products intended for peeling or irritated skin if the concentration of free soluble borate exceeds 1.5 per cent calculated as boric acid | Not to be used for bathing children under three years old Do not use on peeling or irritated skin (Only required if the concentration of free soluble borate exceeds 1.5 per cent calculated as boric acid) |
| Oral hygiene products | 0.1 per cent | Not to be used in products intended for children under three years old | Do not swallow Not to be used for children under three years old | ||
| Other products (excluding bath products and hair waving products | 3 per cent | Not to be used in products intended for children under three years old Not to be used in products intended for peeling or irritated skin if the concentration of free soluble borate exceeds 1.5 per cent calculated as boric acid | Not to be used for children under three years old Do not use on peeling or irritated skin (Only required if the concentration of free soluble borate exceeds 1.5 per cent calculated as boric acid) | ||
| The above-mentioned percentages are calculated as boric acid | |||||
| 1b | Tetraborates | Bath products | 18 per cent | Not to be used in products for children under three years old | Not to be used for bathing children under three years old |
| 2a | Thioglycolic acid and its salts | (a)Hair waving or straightening products for general use | 8 per cent | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. |
(b)Hair waving or straightening products for professional use | 11 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. For professional use only | ||
(c)Depilatories | 5 per cent ready for use | pH 7 to 12.7 | Contains thioglycolate. Follow the instructions. Keep out of reach of children | ||
(d)Other hair-care products which are removed after application | 2 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children | ||
| The above-mentioned percentages are calculated as thioglycolic acid | (a), (b), (c) and (d): The directions for use must incorporate the following:
| ||||
| 2b | Thioglycolic acid esters | (a)Hair waving or straightening products for general use | 8 per cent ready for use | pH 6 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children |
(b)Hair waving or straightening products for professional use | 11 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. For professional use only | ||
| The above-mentioned percentages are calculated as thioglycolic acid | (a) and (b): The directions for use must incorporate the following:
| ||||
| 3 | Oxalic acid, its esters and alkaline salts | Hair-care products | 5 per cent | - | For professional use only |
| 4 | Ammonia | All purposes and products | 6 per cent calculated as NH3 | - | Contains ammonia (not required when concentration is not more than 2 per cent) |
| 5 | Tosylchloramide sodium (INN) [Chloramine-T] | All purposes and products | 0.2 per cent | - | - |
| 6 | Chlorates of alkali metals | Toothpaste | 5 per cent | - | - |
| Other uses | 3 per cent | - | - | ||
| 7 | Dichloromethane | All purposes and products | 35 per cent (and when mixed with 1,1,1-trichloroethane, total concentration must not exceed 35 per cent) | Purity of the dichloromethane must be not less than 99.8 per cent | - |
| 8 | m- and p-Phenylenedi-amines, their N-substituted derivatives and their salts; N-substituted derivatives of o-phenylenediamines (see Note 1), with the exception of those derivatives listed elsewhere in this Schedule) | Oxidizing colouring agents for hair dyeing for general use | 6 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | - | Contains phenylenediamines Can cause an allergic reaction. Do not use to dye eyelashes or eyebrows |
| Oxidizing colouring agents for hair dyeing for professional use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | - | Contains phenylenediamines. For professional use only. Can cause an allergic reaction. Wear suitable gloves | ||
| 9 | Methylphenylenedimines (other than 4-methyl-m-phenylenediamine and its salts), their N-substituted derivatives and their salts (Toluenediamines (other than toluene-1,3-diamine and its salts), their N-substituted derivatives and their salts) (see Note 1) | Oxidizing colouring agents for hair dyeing for general use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | - | Contains phenylene-diamines. Can cause an allergic reaction. Do not use to dye eyelashes or eyebrows |
| Oxidizing colouring agents for hair dyeing for professional use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | - | Contains phenylenediamines. For professional use only. Can cause an allergic reaction. Wear suitable gloves | ||
| 10 | Diaminophenols (see Note 1) | Oxidizing colouring agents for hair dyeing for general use | 10 per cent calculated as free base, subject to the provisions of “Combination Rule A” set out below | - | Contains diaminophenols. Can cause allergic reaction. Do not use to dye eyelashes or eyebrows |
| Oxidizing colouring agents for hair dyeing for professional use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | - | Contains diaminophenols. For professional use only. Can cause allergic reaction. Wear suitable gloves | ||
| 11 | Dichlorophen (INN) [Dichlorophene] | All purposes and products | 0.5 per cent | - | Contains dichlorophen |
| 12 | Hydrogen peroxide and other compounds or mixtures that release hydrogen peroxide including hydrogen peroxide-urea (hydrogen peroxide-carbamide) and zinc peroxide | (a)Hair-care preparations | 12 per cent of H2O2 present or released | - | (a):Wear suitable gloves Contains hydrogen peroxide. Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them |
(b)Skin-care preparations | 4 per cent of H2O2 present or released | - | Contains hydrogen peroxide. Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them | ||
(c)Nail hardening preparations | 2 per cent of H2O2 present or released | - | Contains hydrogen peroxide. Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them | ||
(d)Oral hygiene products | 0.1 per cent of H2O2 present or released | - | - | ||
| 13 | Formaldehyde (see also Part I of Schedule 6) | Nail hardeners | 5 per cent | - | Contains formaldehyde. Protect cuticles with grease or oil. (Not required when concentration is not more than 0.05 per cent) |
| 14 | Hydroquinone | Oxidizing colouring agent for hair dyeing for general use | 0.3 per cent subject to the provisions of “Combination Rule B” set out below | - | Contains hydroquinone. Do not use to dye eyelashes or eyebrows. Rinse eyes immediately if product comes into contact with them |
| Oxidizing colouring agent for hair dyeing for professional use | 0.3 per cent subject to the provisions of “Combination Rule B” set out below | - | For professional use only. Contains hydroquinone. Rinse eyes immediately if product comes into contact with them | ||
| Artificial nail systems for professional use | 0.02 per cent (after mixing for use) subject to the provisions of “Combination Rule B” set out below | - | For professional use only Avoid skin contact Read directions for use carefully | ||
| 15a | Potassium hydroxide and sodium hydroxide | Nail cuticle solvent | 5 per cent calculated as sodium hydroxide (see Note 2) | - | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
| Hair straightener for general use | 2 per cent calculated as sodium hydroxide (see Note 2) | - | Contain alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children | ||
| Hair straightener for professional use | 4.5 per cent calculated as sodium hydroxide (see Note 2)(18) | - | For professional use only. Avoid contact with eyes. Can cause blindness | ||
| pH adjuster for depilatories | PH value not to exceed 12.7 | Keep out of reach of children Avoid contact with the eyes | |||
| Other uses as pH adjuster | PH value not to exceed 11 | - | |||
| 15b | Lithium hydroxide | Hair straightener for general use | 2 per cent calculated as sodium hydroxide (see Note 2) | - | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
| Hair straightener for professional use | 4.5 per cent calculated as sodium hydroxide (see Note 2) | - | For professional use only. Avoid contact with eyes. Can cause blindness | ||
| pH adjuster for depilatories | PH value not to exceed 12.7 | Contains alkali. Keep out of reach of children. Avoid contact with eyes | |||
| Other uses as pH adjuster (for rinse-off products only) | PH value not to exceed 11 | - | |||
| 15c | Calcium hydroxide | Hair straighteners containing two components; calcium hydroxide and a guanidine salt | 7 per cent by weight of calcium hydroxide | - | Contains alkali. Avoid contact with eyes. Keep out of reach of children. Can cause blindness |
| pH adjuster for depilatories | pH value not to exceed 12.7 | Contains alkali. Avoid contact with eyes. Keep out of reach of children. | |||
| Other uses e.g. pH adjuster processing aid | pH value not to exceed 11 | ||||
| 16 | α-Naphthol [1-Naphthol] and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction |
| 17 | Sodium nitrite | Rust inhibitor | 0.2 per cent | Do not use with secondary and/or tertiary amines or other substances forming nitrosamines | - |
| 18 | Nitromethane | Rust inhibitor | 0.3 per cent | - | - |
| 19 | Phenol and its alkali salts | Soaps and shampoos | 1 per cent calculated as phenol | - | Contains phenol |
| 20 | ENTRY DELETED | ||||
| 21 | Quinine and its salts | Shampoos | 0.2 per cent calculated as quinine base | - | - |
| Hair lotions | 0.5 per cent calculated as quinine base | - | - | ||
| 22 | Resorcinol | Oxidizing colouring agent for hair dyeing for general use | 5 per cent subject to the provisions of “Combination Rule B” set out below | - | Contains resorcinol. Rinse hair well after application. Do not use to dye eyelashes or eyebrows. Rinse eyes immediately if product comes into contact with them |
| Oxidizing colouring agent for hair dyeing for professional use | 5 per cent subject to the provisions of “Combination Rule B” set out below | - | Contain resorcinol. For professional use only. Rinse eyes immediately if product comes into contact with them | ||
| Hair lotions and shampoos | 0.5 per cent subject to the provisions of “Combination Rule B” set out below | - | Contains resorcinol | ||
| 23a | Alkali sulphides | Depilatories | 2 per cent calculated as sulphur | PH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes |
| 23b | Alkaline earth sulphides | Depilatories | 6 per cent calculated as sulphur | PH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes |
| 24 | Water-soluble zinc salts with the exception of zinc 4-hydroxybenzene-sulphonate | All purposes and products | 1 per cent calculated as zinc | - | - |
| 25 | Zinc 4-hydroxybenzene-sulphonate [Zinc phenolsulfonate] | Deodorants, antiperspirants and astringent lotions | 6 per cent calculated as percentage of anhydrous substance | - | Avoid contact with eyes |
| 26 | Ammonium monofluoro-phosphate | Oral hygiene products | 0.15 per cent calculated as fluorine. When mixed with other fluorine compounds the total fluorine concentration must not exceed 0.15 per cent | - | Contains ammonium monofluorophosphate |
| 27 | Sodium monofluoro-phosphate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains sodium monofluoro-phosphate |
| 28 | Potassium monofluoro-phosphate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains potassium monofluorophosphate |
| 29 | Calcium monofluoro-phosphate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains calcium monofluorophosphate |
| 30 | Calcium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains calcium fluoride |
| 31 | Sodium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains sodium fluoride |
| 32 | Potassium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains potassium fluoride |
| 33 | Ammonium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains ammonium fluoride |
| 34 | Aluminium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains aluminium fluoride |
| 35 | Stannous fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains stannous fluoride |
| 36 | Hexadecylammonium fluoride [Cetylamine hydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains hexadecylammonium fluoride |
| 37 | 3-(n-Hexadecyl-N-2-hydroxyethylammonio)-propylbis(2-hydroxy-ethyl)ammonium difluoride [Stearyl trihydroxyethyl propylenediamine dihydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains 3-(n-hexadecyl-N-2-hydroxyethylammonio)- propylbis(2-hydroxyethyl)-ammonium difluoride |
| 38 | N,N’,N’—Tris(polyoxyethylene)-N-hexadecylpropylene-diamine dihydrofluoride [Palmityltrihydroxyethyl propylenediamine dihydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains N,N’,N’-tris (polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride |
| 39 | Octadecenylammonium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains octadecenylammonium fluoride |
| 40 | Sodium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains sodium fluorosilicate |
| 41 | Potassium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contain potassium fluorosilicate |
| 42 | Ammonium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains ammonium fluorosilicate |
| 43 | Magnesium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains magnesium fluorosilicate |
| 44 | 1,3-Bis(hydroxymethyl)-imidazolidene-2-thione [Dimethylol ethylene thiourea] | Hair care preparations | 2 per cent | Not to be used in aerosol dispensers | Contains 1,3-bis(hydroxymethyl) imidazolidine-2-thione |
| 45 | Benzyl alcohol (See also Part I of Schedule 6) | Solvent, perfumes and flavourings | - | - | |
| 46 | 6-Methylcoumarin | 0.003 per cent | 0.003 per cent | - | - |
| 47 | Nicomethanol hydrofluoride | Oral hygiene products | As for ammonium monofluorophosphate | - | Contains nicomethanol hydrofluoride |
| 48 | Silver nitrate | Products to dye eyelashes or eyebrows | 4 per cent | - | Contains silver nitrate. Rinse eyes immediately if product comes into contact with them |
| 49 | Selenium disulphide [Selenium sulphide] | Anti-dandruff shampoos | 1 per cent | - | Contains selenium disulphide. Avoid contact with eyes or damaged skin |
| 50 | Aluminium zirconium chloride hydroxide complexes AlxZr(OH)y Clz and aluminium hydroxide glycine complexes | Anti-perspirants | 20 per cent anhydrous aluminium zirconium chloride hydroxide, 5.4 per cent as zirconium | The ratio of the number of aluminium atoms to that of zirconium atoms must be between 2 to 10 The ratio of the number of (Al + Zr) atoms to chlorine atoms must be between 0.9 and 2.1 Not to be used in aerosol dispensers (sprays) | Do not apply to irritated or damaged skin |
| 51 | Quinolin-8-ol and bis(8-hydroxyquinolinium sulphate) (See also Part I of Schedule 3) [Oxyquinoline and Oxyquinoline sulphate] | Stabilizer for hydrogen peroxide in rinse-off hair care preparations | 0.3 per cent calculated as base | - | - |
| Stabilizer for hydrogen peroxide in non rinse-off hair car preparations | 0.3 per cent calculated as base | - | - | ||
| 52 | Methanol | Denaturant for ethanol and isopropyl alcohol | 5 per cent calculated as a percentage of ethanol and isopropyl alcohol | - | - |
| 53 | Etidronic acid and its salts | Hair care | 1.5 per cent expressed as etidronic acid | - | - |
| 54 | 1-Phenoxy-propan-2-ol (See also Part I of Schedule 6) [Phenoxyisopropanol] | Products rinsed off after use | 2 per cent | Prohibited in oral hygiene products | - |
| 55 | Lead acetate | Only for hair dyeing | 0.6 per cent calculated as lead | - | Contains lead acetate. Keep away from children. Avoid all contact with the eyes. Wash hands after use. Do not use to dye eyelashes, eyebrows or moustaches. If irritation develops discontinue use |
| 56 | Magnesium fluoride | Dental hygiene products | 0.15 per cent calculated as fluoride. When mixed with other fluorine compounds the total fluorine concentration must not exceed 0.15 per cent | - | Contains magnesium fluoride |
| 57 | Strontium chloride hexahydrate | (a)Toothpaste | 3.5 per cent calculated as strontium. When mixed with other permitted strontium compounds the total strontium content must not exceed 3.5 per cent | - | Contains strontium chloride Frequent use by children is not advisable |
(b)Shampoo and face care products | 2.1 per cent calculated as strontium. When mixed with other permitted strontium compounds the total strontium content must not exceed 2.1 per cent | - | - | ||
| 58 | Strontium acetate hemihydrate | Toothpaste | 3.5 per cent calculated as strontium. When mixed with other permitted strontium products the total strontium content must not exceed 3.5 per cent | - | Contains strontium acetate. Use by children is not advisable |
| 59 | Talc: hydrated magnesium | (a)Powdery products intended to be used for children under three years of age | - | - | (a):Keep powder away from children’s and mouth |
(b)other products | - | - | - | ||
| 60 | Fatty acid dialkylamides and dialkanolamides | All purposes and products | Maximum secondary amine content: 0.5 per cent | Do not use with nitrosating systems. Maximum secondary amine content: 5 per cent (applies to raw materials. Maximum nitrosamine content: 50 μg/kg (applies to raw materials). Keep in nitrite-free containers | - |
| 61 | Monoalkylamines, Monoalkanolamines and their salts | All purposes and products | Maximum secondary amine content: 0.5 per cent | Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum secondary amine content: 0.5 per cent (applies to raw materials). Maximum nitrosamine content: 50 μg/kg (applies to raw materials). Keep in nitrite-free containers. | - |
| 62 | Trialkylamines, trialkanolamines and their salts | (a)non-rinse-off products | (a)2.5 per cent | Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum secondary amine content: 0.5 per cent (applies to raw materials) Maximum nitrosamine content: 50 μg/kg (applies to raw materials). Keep in nitrite free containers | - |
(b)other products | Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum secondary amine content: 0.5 per cent (applies to raw materials) Maximum nitrosamine content: 50 μg/kg (applies to raw materials). Keep in nitrite free containers | - | |||
| 63 | Strontium hydroxide | pH-regulator in depilatory products | 3.5 per cent calculated as strontium | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with the eyes |
| 64 | Sodium peroxide | Rinse-off hair care preparations for professional use | 4.5 per cent calculated as strontium in the ready-for-use preparation | All products must meet the hydrogen peroxide release requirements | Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them. For professional use only. Wear suitable gloves |
| 65 | Benzalkonium chloride (INN), bromide and saccharinate (eg. Cetalkonium chloride Stearalkonium chloride, Cetearalkonium bromide) | Hair care products rinsed off after use | 3 per cent calculated as benzalkonium chloride | In the finished product the concentration of benzalkonium chloride, bromide and saccharinate with an alkyl chain-length of C14 or less must not exceed 0.1 per cent calculated as benzalkonium chloride | Avoid contact with the eyes |
| 66 | Polyacrylamides | Body-care leave-on products | Maximum residual acrylamide content 0.1 mg/kg Maximum residual acrylamide content 0.5 mg/kg | - | |
| 67 | Amyl cinnamal (CAS No 122-40-7) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 68 | Benzyl alcohol (CAS No 100-51-6) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 69 | Cinnamyl alcohol (CAS No 104-54-1) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 70 | Citral (CAS No 5392-40-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 71 | Eugenol (CAS No 97-53-0) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 72 | Hydroxycitronellal (CAS No 107-75-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 73 | Isoeugenol (CAS No 97-54-1) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 74 | Amylcinnamylalcohol (CAS No 101-85-9) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 75 | Benzyl salicylate (CAS No 118-58-1) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 76 | Cinnamal (CAS No 104-55-2) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 77 | Coumarin (CAS No 91-64-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 78 | Geraniol (CAS No 106-24-1) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 79 | Hydroxymethylpentyl-cyclohexene-carboxaldehyde (CAS No 31906-04-4) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 80 | Anisyl alcohol (CAS No 105-13-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 81 | Benzyl cinnamate (CAS No 103-41-3) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 82 | Farnesol (CAS No 4602-84-0) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 83 | 2-(4-tert-Butylbenzyl) propionaldehyde (CAS No 80-54-6) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 84 | Linalool (CAS No 78-70-6) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 85 | Benzyl benzoate (CAS No 120-51-4) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 86 | Citronellol (CAS No 106-22-9) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 87 | Hexyl cinnamaldehyde (CAS No 101-86-0) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 88 | d-Limonene (CAS No 5989-27-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 89 | Methyl heptin carbonate (CAS No 111-12-6) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 90 | 3-Methyl-4(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one (CAS No 127-51-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 91 | Oak moss extract (CAS No 90028-68-5) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 92 | Treemoss extract (CAS No 90028-67-4) | The presence of the substance must be indicated in the list of ingredients referred to in regulation 7(1) when its concentration exceeds:
| - | ||
| 93 | 2,4-Diaminopyrimidine 3-oxide (CAS No 74638-76-9) | Hair care formulations | 1.5 per cent | - | - |
| 94 | Benzoyl peroxide (CAS No 94-36-0) | Artificial nail systems for professional use | 0.7 per cent (after mixing for use) | - | For professional use only Avoid skin contact Read directions for use carefully |
| 95 | Hydroquinone methyl ether (4-methoxyphenol) (CAS No 150-76-5) | Artificial nail systems for professional use | 0.02 per cent (after mixing for use) | - | For professional use only Avoid skin contact Read directions for use carefully |
Commencement Information
I27Sch. 4 Pt. 2 in force at 11.9.2004 in so far as commencd by inducing regs. 5(2), 6(1), see reg. 1(1)
I28Sch. 4 Pt. 2 in force at 11.3.2005 in so far as commenced by inducing reg. 7(2)(9), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) | (6) | (7) |
|---|---|---|---|---|---|---|
| Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information | Permitted for supply until |
Combination Rules A. Where a cosmetic product contains two or more substances to which this Combination Rule applies, the concentration in the product of each of those substances shall be such that the sum of the relevant quotients for those substances (as defined in Rule C below) shall not exceed 1. B. Where a cosmetic product contains the substances to which this Combination Rule applies, the concentration in the product of each of those substances shall be such that the sum of the relevant quotients for those substances (as defined in Rule C below) shall not exceed 2; but the concentration of each substances shall not in any event exceed the limit specified for the substance in respect of the product in column 4 above. C. The relevant quotient for each substance is the actual concentration of the substance in the product divided by the maximum concentration specified for the substance in respect of the product in Column 4 of this Schedule. | ||||||
| Note 1: May be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 1. | ||||||
| Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as a percentage of sodium hydroxide. In cases of mixtures, the sun must not exceed the limits given in column 4. | ||||||
| 1 | C.I. Basic Blue 7 (CAS No 2390-60-5) | Non-oxidising colouring agents for hair dyeing | 0.2 per cent | — | Can cause allergic reaction | 30.9.2004 |
| 2 | 2-Amino-3-nitrophenol (CAS No 603-85-0) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 3 | 4-Amino-3-nitrophenol (CAS No 610-81-1) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 4 | Naphthalene-2,7-diol (CAS No 582-17-2) and its salts | Oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.5 per cent | — | 30.9.2004 |
| 5 | 3-Aminophenol (CAS No 591-27-5) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 6 | 3,4-Dimethylpyridine-2,6-diol (CAS No 84540-47-6) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 7 | 4-(3-Hydroxypropyl)amino-3-nitrophenol (CAS No 92952-81-3) and its salts | Oxidising colouring agents for hair dyeing | 5.2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 2.6 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 2.6 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 2.6 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 8 | 6-Nitropyridine-2,5-diamine (CAS No 69825-83-8) and its salts | Non-oxidising colouring agent for hair dyeing | 3 per cent | — | Can cause allergic reaction | 30.9.2004 |
| 9 | HC Blue No. 11 (CAS No 23920-15-2) and its salts | Oxidising colouring agent for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 10 | 2-(2-Nitro-p-toluidino)-ethanol (CAS No 100418-33-5) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 11 | 2-(2-Hydroxyethylamino)-4,6-dinitrophenol (CAS No 99610-72-7) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 12 | 4-Methylaminophenol (CAS No 150-75-4) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| 13 | 2-(2,4-Diamino-5-methylphenoxy)ethanol (CAS No 141614-05-3) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| 14 | HC Violet No. 2 (CAS No 104226-19-9) and its salts | Non-oxidising colouring agent for hair dyeing | 2 per cent | — | — | 30.9.2004 |
| 15 | 2-(2,6-Dinitro-p-anisidino)ethanol (CAS No 122252-11-3) and its salts | Non-oxidising colouring agent for hair dyeing | 3 per cent | — | Can cause allergic reaction | 30.9.2004 |
| 16 | HC Blue No. 12 (CAS No 104516-93-0) and its salts | Oxidising colouring agents for hair dyeing | 1.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.75 per cent | Can cause allergic reaction | 30.9.2004 |
| Non-oxidising colouring agent for hair dyeing | 1.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.75 per cent | Can cause allergic reaction | 30.9.2004 | ||
| 17 | 4-Ethoxy-6-methyl-m-phenylenediamine (CAS No 113715-25-6) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 18 | 4,4’-(Trimethylenedioxy)di-m-phenylenediamine (CAS No 81892-72-0) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 19 | 3-Amino-2,4-dichlorophenol (CAS No 61693-43-4) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 20 | 3-Methyl-l-phenyl-5-pyrazolone (CAS No 89-25-8) and its salts | Oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | Can cause allergic reaction | 30.9.2004 |
| 21 | 5-(2-Hydroxyethyl)amino- o-cresol (CAS No 55302-96-0) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 22 | 3,4 Dihydro-2H-1,4-benzoxazin-6-ol (CAS No 26021-57-8) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | Can cause allergic reaction | 30.9.2004 |
| 23 | Naphthalene-1,7-diol (CAS No 575-38-2) and its salts | Oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.5 per cent | Can cause allergic reaction | 30.9.2004 |
| 24 | HC Yellow No.10 (CAS No 109023-83-8) and its salts | Non-oxidising colouring agents for hair dyeing | 0.2 per cent | — | — | 30.9.2004 |
| 25 | 2,6-Dimethoxy-3,5- pyridinediamine (CAS No 85679-78-3) and its salts | Oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | Can cause allergic reaction | 30.9.2004 |
| 26 | HC Orange No.2 (CAS No 85765-48-6) and its salts | Non-oxidising colouring agent for hair dyeing | 1 per cent | — | — | 30.9.2004 |
| 27 | HC Violet No.1 (CAS No 82576-75-8) and its salts | Oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | — | 30.9.2004 | ||
| 28 | 2-(3-Methylamino-4-nitrophenoxy)ethanol (CAS No 59820-63-2) and its salts | Non-oxidising colouring agents for hair dyeing | 1 per cent | — | — | 30.9.2004 |
| 29 | 2-(2-Methoxy-4-nitroanilino)ethanol (CAS No 66095-81-6) and its salts | Non-oxidising colouring agents for hair dyeing | 1 per cent | — | — | 30.9.2004 |
| 30 | 2-(4-Amino-2-chloro-5-nitroanilino)ethanol (CAS No 50610-28-1) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 | ||
| 31 | HC Red No. 13 (CAS No 94158-13-1) | Oxidising colouring agents for hair dyeing | 2.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.25 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 2.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.25 per cent | — | 30.9.2004 | ||
| 32 | Naphthalene-1,5-diol (CAS No 83-56-7) and its salts | Oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.5 per cent | — | 30.9.2004 |
| 33 | 2,2’-[2-Hydroxy-trimethylenebis(4-aminophenyl)imino]diethanol (CAS No 128729-30-6) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | Can cause allergic reaction | 30.9.2004 |
| 34 | 2-Aminophenol (CAS No 95-55-6) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| 35 | 5-Amino-o-cresol (CAS No 2835-95-2) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 36 | 2-(2,4-Diamino-phenoxy)ethanol (CAS No 66422-95-5) and its salts | Oxidising colouring agents for hair dyeing | 4 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 2 per cent | — | 30.9.2004 |
| 37 | 2-Methylresorcinol (CAS No 608-25-3) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| 38 | 4-Amino-m-cresol (CAS No 2835-99-6) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 39 | 2-Amino-4-hydroxyethyl-aminoanisole (CAS No 83763-47-7) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 40 | 3,4-Diaminobenzoic acid (CAS No 619-05-6) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| 41 | 6-Amino-o-cresol (CAS No 17672-22-9) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 42 | 2-Aminomethyl-p-aminophenol (CAS No 79352-72-0) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 43 | 2-Amino-2-(2-hydroxyethylaminomethyl) (CAS No 110952-46-0 and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 44 | N-(2-Hydroxyethyl)-3,4-methylenedioxyaniline (CAS No 81329-90-0) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| 45 | C.I. Acid Black 52 (CAS No 3618-58-4) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.per cent | — | 30.9.2004 |
| 46 | 2-Nitro-p-phenylenediamine (CAS No 5307-14-2) and its salts | Oxidising colouring agents for hair dyeing | 0.3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.15 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 0.3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.15 per cent | — | 30.9.2004 | ||
| 47 | HC Blue No.2 (CAS No 33229-34-4) and its salts | Non-oxidising colouring agents for hair dyeing | 2.8 per cent | — | — | 30.9.2004 |
| 48 | 4-(2-Hydroxyethylamino)-3-nitrophenol (CAS No 65235-31-6) and its salts | Oxidising colouring agents for hair dyeing | 6 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 3 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 6 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 3 per cent | — | 30.9.2004 | ||
| 49 | 2-(4-Nitrophenylamino)-ethylurea (CAS No 27080-42-8) and its salts | Oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | — | 30.9.2004 | ||
| 50 | HC Red No. 10 (CAS No 95576-89-9) + HC Red No. 11 (CAS No 95576-92-4) and their salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 | ||
| 51 | HC Yellow No. 6 (CAS No 104333-00-8) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 | ||
| 52 | HC Yellow No.12 (CAS No 59320-13-7) and its salts | Oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.5 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 0.5 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.5 per cent | — | 30.9.2004 | ||
| 53 | HC Blue No. 10 (CAS No 102767-27-1) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| 54 | HC Blue No. 9 (CAS No 114087-47-1) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 1 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 | ||
| 55 | 2-Chloro-6-ethylamino-4-nitrophenol (CAS No 131657-78-8) and its salts | Oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1.5 per cent | — | 30.9.2004 | ||
| 56 | 2-Amino-6-chloro-4-nitrophenol (CAS No 6358-09-4) and its salts | Oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 2 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 1 per cent | — | 30.9.2004 | ||
| 57 | C.I. Basic Blue 26 (CAS No 2580-56-5) (C.I. No. 44045) | Oxidising colouring agents for hair dyeing | 0.5% | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 0.5% | In combination with hydrogen peroxide the maximum use concentration upon application is 0.25 per cent | — | 30.9.2004 | ||
| 58 | C.I. Acid Red 33 (CAS No 3567-66-6) (C.I. No. 17200) | Non-oxidising colouring agents for hair dyeing | 2 per cent | — | — | 30.9.2004 |
| 59 | C. I. Food Red 1 (CAS No 4548-53-2) (C.I. No. 14700) | Non-oxidising colouring agents for hair dyeing | 2 per cent | — | — | 30.9.2004 |
| 60 | C.I. Basic Violet 14 (CAS No 632-99-5) (C.I. No. 42510) | Oxidising colouring agents for hair dyeing | 0.3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.15 per cent | — | 30.9.2004 |
| Non-oxidising colouring agents for hair dyeing | 0.3 per cent | In combination with hydrogen peroxide the maximum use concentration upon application is 0.15 per cent | — | 30.9.2004 | ||
| 61 | 1-tert-Butyl-3,5-dimethyl-2,4,6-trinitrobenzene (CAS No 81-15-2) (musk xylene) | All cosmetic products, with the exception of oral care products | 1 per cent in fine fragrance 0.4 per cent in eau de toilette 0.03 per cent in other products | — | — | 30.9.2004 |
| 62 | 4’-tert-Butyl-2’,6’-dimethyl-3’, 5’-dinitroacetophenone (CAS No 81-14-1) (musk ketone) | All cosmetic products, with the exception of oral care products | 1.4 per cent in fine fragrance 0.56 per cent in eau de toilette 0.042 per cent in other products | — | — | 30.9.2004 |
Regulation 5(2) and 7(9)
In this Schedule the colouring agents referred to in regulation 5(2)(d) are—
(i)those identified in column 1 either by name or by colour index number (the colour index numbers being those specified in the fourth edition of The Colour Index published by the Society of Dyers and Colourists and the American Society of Textile Chemists and Colourists (available by on-line subscription at http://www.colour-index.org/). ;
(ii)lakes or salts of these colouring agents which do not use substances prohibited under Schedule 3.
In the case of colouring agents identified by the addition of (*) to the name or colour index number, the insoluble barium, strontium and zirconium lakes, salts and pigments of these colouring agents shall also be permitted. They must pass the test for insolubility which will be determined by the procedure laid down in Article 8 of the Directive.
Colouring agents whose number is preceded by the letter ‘E’ in accordance with the EEC Directive of 23rd October 1962 on the approximation of the rules of Member States concerning foodstuffs and colouring matter (19), as amended (20) adapted (21) and replaced in part (22) must fulfil the purity requirements laid down in those Directives.
Commencement Information
I29Sch. 5 Pt. I in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I30Sch. 5 Pt. I in force at 11.3.2005 in so far as commenced by inducing reg. 7(9), see reg. 1(2)
In column 3 of this Schedule, the entry “X” in a sub-column means that the colouring agent must not be used other than as follows—
Sub-column 1 = Colouring agents allowed in all cosmetic products;
Sub-column 2 = Colouring agents allowed in all cosmetic products except those intended to be applied in the vicinity of the eyes, in particular eye make-up and eye make-up remover;
Sub-column 3 = Colouring agents allowed exclusively in cosmetic products except cosmetic products intended to come into contact with the mucous membranes;
Sub-column 4 = Colouring agents allowed exclusively in cosmetic products intended to come into contact only briefly with the skin
| (1) | (2) | (3) | (4) | |||
|---|---|---|---|---|---|---|
| Name or colour index number | Colour | Type of production Field of application | Other requirement | |||
| 1 | 2 | 3 | 4 | |||
| 10006 | Green | X | ||||
| 10020 | Green | X | ||||
| 10316* | Yellow | X | ||||
| 11680 | Yellow | X | ||||
| 11710 | Yellow | X | ||||
| 11725 | Orange | X | ||||
| 11920 | Orange | X | ||||
| 12010 | Red | X | ||||
| 12085* | Red | X | 3 per cent maximum concentration in the finished product | |||
| 12120 | Red | X | ||||
| 12150 | Red | X | ||||
| 12370 | Red | X | ||||
| 12420 | Red | X | ||||
| 12480 | Brown | X | ||||
| 12490 | Red | X | ||||
| 12700 | Yellow | X | ||||
| 13015 | Yellow | X | E 105 | |||
| 14270 | Orange | X | E 103 | |||
| 14700 | Red | X | ||||
| 14720 | Red | X | E 122 | |||
| 14815 | Red | X | E 125 | |||
| 15510* | Orange | X | ||||
| 15525 | Red | X | ||||
| 15580 | Red | X | ||||
| 15620 | Red | X | ||||
| 15630* | Red | X | 3 per cent maximum concentration in the finished product | |||
| 15800 | Red | X | ||||
| 15850* | Red | X | ||||
| 15865* | Red | X | ||||
| 15800 | Red | X | ||||
| 15980 | Orange | X | E 111 | |||
| 15985* | Yellow | X | E 110 | |||
| 16035 | Red | X | ||||
| 16185 | Red | X | E 123 | |||
| 16230 | Orange | X | ||||
| 16255* | Red | X | E 124 | |||
| 16290 | Red | X | E 126 | |||
| 17200* | Red | X | ||||
| 18050 | Red | X | ||||
| 18130 | Red | X | ||||
| 18690 | Yellow | X | ||||
| 18736 | Red | X | ||||
| 18820 | Yellow | X | ||||
| 18965 | Yellow | X | ||||
| 19140* | Yellow | X | E 102 | |||
| 20040 | Yellow | X | Maximum 3,3’-dimethyl-benzidine concentration in the colouring agent: 5 mg/kg | |||
| 20170 | Orange | X | ||||
| 20470 | Black | X | ||||
| 21100 | Yellow | X | Maximum 3,3’-dichloro-benzidine concentration in the colouring agent: 5 mg/kg | |||
| 21108 | Yellow | X | Maximum 3,3’-dichloro-benzidine concentration in the colouring agent: 5 mg/kg | |||
| 21230 | Yellow | X | ||||
| 24790 | Red | X | ||||
| 26100 | Red | X | Purity criteria: aniline ≤ 0.2 per cent, 2-naphthol ≤ 0.2 per cent, azobenzen-4-amine ≤ 0.1 per cent, 1-phenylazo-2- naphthol ≤ 3 per cent, 1-[2-(phenylazo)phenylazo]-2-naphthol ≤ 2 per cent | |||
| 27290* | Red | X | ||||
| 27755 | Black | X | E 152 | |||
| 28440 | Black | X | E 151 | |||
| 40215 | Orange | X | ||||
| 40800 | Orange | X | ||||
| 40820 | Orange | X | E 160e | |||
| 40825 | Orange | X | E 160f | |||
| 40850 | Orange | X | E 161g | |||
| 42045 | Blue | X | ||||
| 42051* | Blue | X | ||||
| 42053 | Green | X | ||||
| 42080 | Blue | X | ||||
| 42090 | Blue | X | ||||
| 42100 | Green | X | ||||
| 42170 | Green | X | ||||
| 42510 | Violet | X | ||||
| 42520 | Violet | X | Maximum concentration in the finished product: 5 mg/kg | |||
| 42735 | Blue | X | ||||
| 44045 | Blue | X | ||||
| 44090 | Green | X | E 142 | |||
| 45100 | Red | X | ||||
| 45190 | Violet | X | ||||
| 45220 | Red | X | ||||
| 45350 | Yellow | X | 6 per cent. maximum concentration in the finished product | |||
| 45370 | Orange | X | Not more than 1 per cent 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 2 per cent 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | |||
| 45380* | Red | X | As immediately above | |||
| 45396 | Orange | X | When used in lipstick, the colouring agent is allowed only in free acid form and in a maximum concentration of 1 per cent | |||
| 45405 | Red | X | Not more than 1 per cent 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | |||
| 45410* | Red | X | As immediately above | |||
| 45425 | Red | X | Not more than 1 per cent 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 3 per cent 2-(iodo-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | |||
| 45430* | Red | X | As immediately above, E 127 | |||
| 47000 | Yellow | X | ||||
| 47005 | Yellow | X | E 104 | |||
| 50325 | Violet | X | ||||
| 50420 | Black | X | ||||
| 51319 | Violet | X | ||||
| 58000 | Red | X | ||||
| 59040 | Green | X | ||||
| 60724 | Violet | X | ||||
| 60725 | Violet | X | ||||
| 60730 | Violet | X | ||||
| 61565 | Green | X | ||||
| 61570 | Green | X | ||||
| 61585 | Blue | X | ||||
| 62045 | Blue | X | ||||
| 69800 | Blue | X | E 130 | |||
| 69825 | Blue | X | ||||
| 71105 | Orange | X | ||||
| 73000 | Blue | X | ||||
| 73015 | Blue | X | E 132 | |||
| 73360 | Red | X | ||||
| 73385 | Violet | X | ||||
| 73900 | Violet | X | ||||
| 73915 | Red | X | ||||
| 74100 | Blue | X | ||||
| 74160 | Blue | X | ||||
| 74180 | Blue | X | ||||
| 74260 | Green | X | ||||
| 75100 | Yellow | X | ||||
| 75120 | Orange | X | E 160b | |||
| 75125 | Yellow | X | E 160d | |||
| 75130 | Orange | X | E 160a | |||
| 75135 | Yellow | X | E 161d | |||
| 75170 | White | X | ||||
| 75300 | Yellow | X | E 100 | |||
| 75470 | Red | X | E 120 | |||
| 75810 | Green | X | E 140 and E 141 | |||
| 77000 | White | X | ||||
| 77002 | White | X | ||||
| 77004 | White | X | ||||
| 77007 | Blue | X | ||||
| 77015 | Red | X | ||||
| 77120 | White | X | ||||
| 77163 | White | X | ||||
| 77220 | White | X | E 170 | |||
| 77231 | White | X | ||||
| 77266 | Black | X | ||||
| 77267 | Black | X | ||||
| 77268:1 | Black | X | E 153 | |||
| 77288 | Green | X | Free from chromate ions | |||
| 77289 | Green | X | Free from chromate ions | |||
| 77346 | Green | X | ||||
| 77400 | Brown | X | ||||
| 77480 | Brown | X | E 175 | |||
| 77489 | Orange | X | E 172 | |||
| 77491 | Red | X | E 172 | |||
| 77492 | Yellow | X | E 172 | |||
| 77499 | Black | X | E 172 | |||
| 77510 | Blue | X | Free from cyanide ions | |||
| 77713 | White | X | ||||
| 77742 | Violet | X | ||||
| 77745 | Red | X | ||||
| 77820 | White | X | E 174 | |||
| 77891 | White | X | E 171 | |||
| 77947 | White | X | ||||
| Acid Red 195 | Red | X | ||||
| Aluminium, zinc, magnesium and calcium stearates | White | X | ||||
| Anthocyanins | Red | X | E 163 | |||
| Beetroot red | Red | X | E 162 | |||
| Bromocresol green | Green | X | ||||
| Bromothymol blue | Blue | X | ||||
| Caramel | Brown | X | E 150 | |||
| Capsanthin, capsorubin | Orange | X | E 160c | |||
| Lactoflavin | Yellow | X | E 101 | |||
Commencement Information
I31Sch. 5 Pt. II in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I32Sch. 5 Pt. II in force at 11.3.2005 in so far as commence by inducing reg. 7(9), see reg. 1(2)
In column 3 of this Schedule, the entry “X” in a sub-column means that the colouring agent must not be used other than as follows—
Sub-column 1 = Colouring agents allowed in all cosmetic products;
Sub-column 2 = Colouring agents allowed in all cosmetic products except those intended to be applied in the vicinity of the eyes, in particular eye make-up and eye make-up remover;
Sub-section 3 = Colouring agents allowed exclusively in cosmetic products intended not to come into contact with the mucous membranes;
Sub-column 4 = Colouring agents allowed exclusively in cosmetic products intended to come into contact only briefly with the skin.
| (1) | (2) | (3) | (4) | (5) | |||
|---|---|---|---|---|---|---|---|
| Name or colour index number | Colour | Type of production Field of application | Other requirement | Cosmetic product supplied until | |||
| Note: There are no entries in this Part at the date that these Regulations are made. | |||||||
| 1 | 2 | 3 | 4 | ||||
Regulations 5(2) and 7(2)
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in column 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used or contained other than in the types of product specified in column 3. The concentration of the substance, when it is used as a preservative, in a product may not exceed the limit set out in column 4. Where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall not calculated by reference to the mixture. Other requirements are specified in column 5.
In column 4 of this Schedule, “A” indicates that the concentration of the substance in a product may exceed the limit set out in that column provided that —
(b)the presence of any excess of the substance in a product over the concentration so set out is not for the primary purpose of inhibiting the development of micro-organisms; and
(c)the purpose for which any such excess is present in the product is apparent from the labelling of the product.
In this Schedule—
“salt” means salts of the cations sodium, potassium, calcium, magnesium, ammonium and ethanolamines and of the anions chloride, bromide, sulphate and acetate;
“ester” means esters of methyl, ethyl, propyl, isopropyl, butyl, isobutyl and phenyl.
In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
All preservative substances containing formaldehyde or any substances named in this Schedule which release formaldehyde must be labelled with the warning “contains formaldehyde” when the concentration of formaldehyde in the final product exceeds 0.05 per cent.
Names which appear in square brackets in column 2 of this Schedule are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC (23).
Regulation 1(3) provides that until 24th March 2005 entry 36 in Part 1 of this Schedule shall be inserted into Part 1 of this Schedule as it appears in the Cosmetic Products (Safety) Regulations 2003(24). From 24th March 2004 entry 36 shall have effect as it appears in Part 1 of this schedule.
Commencement Information
I33Sch. 6 Pt. I in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I34Sch. 6 Pt. I in force at 11.3.2005 in so far as commenced by inducing reg. 7(2), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) | (6) |
|---|---|---|---|---|---|
| Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information |
| 1 | Benzoic acid, its salts and esters | All products | 0.5 per cent (expressed as acid) | A — | — |
| 2 | Propionic acid and its salts | All products | 2 per cent (expressed as acid) | A — | — |
| 3 | Salicylic acid and its salts | All products | 0.5 per cent (expressed as acid) | A Not to be used in preparations for children under three years of age except for shampoos | Not to be used for children under three years of age (solely for products which might be used for children under three years of age and which remain in prolonged contact with the skin) |
| 4 | Sorbic acid (hexa-2,4-dienoic acid) and its salts | All products | 0.6 per cent (expressed as acid) | A — | — |
| 5 | Formaldehyde and para-formaldehyde | For oral hygiene | 0.1 per cent (expressed as free formaldehyde) | Not to be used in aerosol dispensers (sprays) | — |
| 6 | ENTRY DELETED | ||||
| 7 | Biphenyl-2-ol [o-phenylphenol] and its salts | All products | 0.2 per cent (expressed as the phenol) | A — | — |
| 8 | Pyrithione zinc (INN) [Zinc pyrithione] | Products rinsed off after use | 0.5 per cent | A Not to be used in oral hygiene products | — |
| 9 | Inorganic sulphites and hydrogen sulphites | All products | 0.2 per cent (expressed as free SO2) | A — | — |
| 10 | Sodium iodate | Products rinsed off after use | 0.1 per cent | — | — |
| 11 | Chlorobutanol (INN) | All products | 0.5 per cent | Not to be used in aerosol dispensers (sprays) | Contains chlorobutanol |
| 12 | 4-Hydroxybenzoic acid and its salts and esters [the Parabens] | All products | 0.4 per cent (expressed as acid) for 1 ester, 0.8 per cent (expressed as acid) for mixtures of esters | A — | — |
| 13 | 3-Acetyl-6-methylpyran-2,4(3H)-dione [Dehydroacetic acid] and its salts | All products | 0.6 per cent(expressed as acid) | Not to be used in aerosol dispensers (sprays) | — |
| 14 | Formic acid and its sodium salt | All products | 0.5 per cent (expressed as acid) | A — | — |
| 15 | 3,3’-Dibromo-4,4’-hexa-methylenedioxydibenzamidine [Dibromohexamidine] and its salts (including isethionate) | All products | 0.1 per cent | — | — |
| 16 | Thiomersal (INN) [Thimerosal] | Eye make-up and eye make-up remover | 0.007 per cent calculated as mercury. When mixed with other authorised mercury compounds total mercury concentration must not exceed 0.007 per cent | — | Contains thiomersal |
| 17 | Phenylmercuric salts (including borate) | Eye make-up and eye make-up remover | 0.007 per cent calculated as mercury. When mixed with other authorised mercury compounds total mercury concentration must not exceed 0.007 per cent | — | Contains phenylmercuric compounds |
| 18 | Undec-10-enoic acid [Undecylenic acid] and its salts | All products | 0.2 per cent (expressed as acid) | A — | — |
| 19 | Hexetidine (INN) | Products rinsed off after use | 0.1 per cent | A — | — |
| 20 | 5-Bromo-5-nitro-1,3-dioxane | Products rinsed off after use | 0.1 per cent | Avoid formatation of nitrosamines | — |
| 21 | Bronopol (INN) [2-Bromo-2-nitropropane-1,3-diol] | All products | 0.1 per cent | A Avoid formatation of nitrosamines | — |
| 22 | 2,4-Dichlorobenzyl alcohol [Dichlorobenzyl alcohol] | All products | 0.15 per cent | A — | — |
| 23 | Triclocarban (INN) | All products | 0.2 per cent | A Purity criteria: 3,3’,4,4’-tetra-chloroazobenzene < 1 mg/kg | — |
| 24 | 4-Chloro-m-cresol [p-Chloro-m-cresol] | Not to be used in products intended to come into contact with mucous membranes | 0.2 per cent | A — | — |
| 25 | Triclosan (INN) | All products | 0.3 per cent | A — | — |
| 26 | 4-Chloro-3,5-xylenol [Chloroxylenol] | All products | 0.5 per cent | A — | — |
| 27 | 3,3’-Bis(l-hydroxymethyl-2,5-dioxoimidazolidin-4-yl)-1,1’-methylenediurea [Imidazolidinyl urea] | All products | 0.6 per cent | A — | — |
| 28 | Poly(l-hexamethylenebiguanide hydrochloride) [Polyaminopropyl biguanide] | All products | 0.3 per cent | A — | — |
| 29 | 2-Phenoxyethanol [Phenoxyethanol] | All products | 1.0 per cent | A — | — |
| 30 | Hexamethylenetetramine (Methenamine (INN)) [Methenamine] | All products | 0.15 per cent | A — | — |
| 31 | Methenamine 3-chloroallylo-chloride (INNM) [Quaternium-15] | All products | 0.2 per cent | — | — |
| 32 | 1-(4-Chlorophenoxy)-1-(imidazol-l-yl)-3,3-dimethylbutan-2-one (Climbazole (INN)) [Climbazole] | All products | 0.5 per cent | A — | — |
| 33 | 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione [DMDM Hydantoin] | All products | 0.6 per cent | A — | — |
| 34 | Benzyl alcohol (see also Part I of Schedule 4) | All products | 1.0 per cent | A — | — |
| 35 | 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone and its monoethanolamine salt [Piroctone olamine] | Products rinsed off after use | 1.0 per cent | A — | — |
| Other products | 0.5 per cent | A — | |||
| 36 | 2-Bromo-2-(bromomethyl) glutaronitrile (1,2-dibromo-2,4-dicyanobutane)[Methyldibromo glutaronitrile] | Rinse-off products only | 0.1 per cent | — | — |
| 37 | 6,6-Dibromo-4,4-dichloro-2,2’-methylenediphenol [Bromochlorophen] | All products | 0.1 per cent | A — | — |
| 38 | 4-Isopropyl-m-cresol [o-Cymen-5-ol] | All products | 0.1 per cent | — | — |
| 39 | Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one with magnesium chloride and magnesium nitrate [Methylchloroisothiazolinone and Methylisothiazolinone] | All products | 0.0015 per cent of a mixture in the ratio 3:1 of 5-chloro-2-methylisothiazol-3(2H)-one to 2-methylisothiazol-3(2H)-one | — | — |
| 40 | 2-Benzyl-4-chlorophenol [Chlorophene] | All products | 0.2 per cent | — | — |
| 41 | 2-Chloroacetamide [Chloroacetamide] | All products | 0.3 per cent | — | Contains chloroacetamide |
| 42 | Chlorhexidine (INN) and its digluconate, diacetate and dihydrochloride | All products | 0.3 per cent | A — | — |
| 43 | 1-Phenoxypropan-2-ol [Phenoxyisopropanol] (see also Part 1 of Schedule 4) | Products rinsed off after use | 1.0 per cent | — | — |
| 44 | Alkyl (C12-C22)-trimethyl-ammonium bromide and chloride (Cetrimonium bromide (INN) and Cetrimonium chloride (INNM)) | All products | 0.1 per cent | A — | — |
| 45 | 4,4-Dimethyl-1,3-oxazolidine [Dimethyloxazolidine] | All products | 0.1 per cent | The pH of the finished product must not be lower than 6 | — |
| 46 | 1-[1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea [Diazolidinyl urea] | All products | 0.5 per cent | — | — |
| 47 | Hexamidine (INN) (4,4’-(Hexamethylenedioxy)-dibenzamidine) and its salts, including isethionate and p-hydroxybenzoate | All products | 0.1 per cent | A — | — |
| 48 | Glutaraldehyde (pentane-1,5-dial) [Glutaral] | All products | 0.1 per cent | Prohibited in aerosols (sprays) | Contains glutaraldehyde (where glutaraldehyde concentration in the finished product exceeds 0.05 per cent) |
| 49 | 5-Ethyl-3,7-dioxa-1-azabicyclo[3.3.0]octane [7-Ethylbicyclo-oxazolidine] | All products | 0.3 per cent | Prohibited in oral hygiene products and in products intended to come into contact with mucous membranes | — |
| 50 | Chlorphenesin (INN) [Chlorphensin] | All products | 0.3 per cent | — | — |
| 51 | Sodium N-hydroxymethyl-glycinate [Sodium hydroxymethylglycinate] | All products | 0.5 per cent | — | — |
| 52 | Silver chloride deposited on titanium dioxide | Not to be used in products for children under three years of age, in oral hygiene products and in products intended for application around the eyes and on the lips | 0.004 per cent, calculated as silver chloride | The ratio of titanium dioxide to silver chloride shall be 4:1 by mass | — |
| 53 | Benzethonium chloride (INN) [Benzethonium chloride] | Products rinsed off after use | 0.1 per cent | — | — |
| 54 | Benzalkonium chloride, bromide and saccharinate | All products | 0.1 per cent calculated as benzalkonoium chloride | A — | Avoid contact with eyes |
| 55 | Benzylhemiformal | Products rinsed off after use | 0.15 per cent | — | — |
| 56 | 3-lodoprop-2-ynyl butylcarbamate [Iodopropynyl butylcarbamate] | Not to be used in oral hygiene and lip products | 0.05 per cent | — | Contains iodine (Only required where the 3-iodoprop-2-ynyl butylcarbamate concentration in products intended to remain on the skin exceeds 0.02 per cent) |
Commencement Information
I35Sch. 6 Pt. 2 in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I36Sch. 6 Pt. 2 in force at 11.3.2005 in so far as commenced by indcuing reg. 7(2), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) | (6) | (7) |
|---|---|---|---|---|---|---|
| Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information | Permitted for supply until |
| Note: There are no entries in this Part at the date that these Regulations are made. | ||||||
Regulations 5(2), 7(2) and 7(9)
In this schedule, the matters specified in columns 3, 4 and 5 which apply to a particular substance are those set out to the right of its name as mentioned in column 2. The concentration of the substance in a product may not exceed the limit specified in column 3. Where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 4. In column 3 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
Names which appear in square brackets in column 2 are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC (25)
Commencement Information
I37Sch. 7 Pt. 1 in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I38Sch. 7 Pt. 1 in force at 11.3.2005 in so far as commenced by inducing reg. 7(2)(9), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) |
|---|---|---|---|---|
| Reference Number | Name of substance | Maximum concentration of substance in product | Other requirements | Required information |
| 1 | 4-Aminobenzoic acid [PABA] | 5 per cent | — | — |
| 2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulphate [Camphor benzalkonium methosulfate] | 6 per cent | — | — |
| 3 | Homosalate (INN) | 10 per cent | — | — |
| 4 | Oxybenzone (INN) [Benzophenone-3] | 10 per cent | — | Contains oxybenzone. (Not required when concentration is not more than 0.5 per cent, and when the substance is only intended to protect the product) |
| 5 | ENTRY DELETED | |||
| 6 | 2-Phenylbenzimidazole-5-sulphonic acid [Phenylbenzimidazole sulfonic acid] and its potassium, sodium and triethanolamine salts | 8 per cent (expressed as acid) | — | — |
| 7 | 3,3-(1,4-Phenylenedimethylene)bis(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonic acid) [Terephthalylidene dicamphor sulfonic acid] and its salts | 10 per cent (expressed as acid) | — | — |
| 8 | 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dione (Avobenzone (INN)) [Butyl methoxy dibenzoylmethane] | 5 per cent | — | — |
| 9 | α-(2-Oxoborn-3-ylidine)toluene-4-sulphonic acid [Benzylidene camphor sulfonic acid] and its salts | 6 per cent (expressed as acid) | — | — |
| 10 | 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate [Octocrylene] | 10 per cent (expressed as acid) | — | — |
| 11 | Polymer of N-[(2 and 4)-[2-oxoborn-3-ylidene)methyl]benzyl]acrylamide Polyacrylamidomethyl benzylidene camphor] | 6 per cent | — | — |
| 12 | 2-Ethylhexyl 4-methoxycinnamate [Octyl methoxycinnamate] | 10 per cent | — | — |
| 13 | Ethoxylated ethyl-4-aminobenzoate [PEG-25 PABA] | 10 per cent | — | — |
| 14 | Isopentyl 4-methoxycinnamate [Isoamyl p-methoxycinnamate] | 10 per cent | — | — |
| 15 | Tris(2-ethylhexyl) 4,4’4”-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate [Octyl triazone] | 5 per cent | — | — |
| 16 | 2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-l-(trimethylsilyloxy)-disiloxan-1-yl]propyl]phenol [Drometrizole trisiloxane] | 15 per cent | — | — |
| 17 | Bis(2-ethylhexyl) 4,4’-[6-tert-butylcarbamoylanilino)-1,3,5-triazine-2,4-diyldiimino]dibenzoate | 10 per cent | — | — |
| 18 | 3-(4-Methylbenzylidine)bornan-2-one [4-Methylbenzylidene camphor] | 4 per cent | — | — |
| 19 | 3-Benzylodenebornan-2-one [3-Benzylidene camphor | 2 per cent | — | — |
| 20 | 2-Ethylhexyl salicylate [Octyl salicylate] | 5 per cent | — | — |
| 21 | 2-Ethylhexyl 4-dimethylaminobenzoate [Octyl dimethyl PABA] | 8 per cent | — | — |
| 22 | 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid [Benzophenone-4] and its sodium salt [Benzophenone-5] (Sulisobenzone (INN) and Sulisobenzone sodium (INNM)) | 5 per cent (expressed as acid) | — | — |
| 23 | 2-2’-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol] | 10 per cent | — | — |
| 24 | diSodium 2,2’-(1,4-phenylene)bis(lH-benzimidazole-4,6-disulfonate) | 10 per cent (expressed as acid) | — | — |
| 25 | 5,5’-Bis(2-ethylhexyloxy)-2,2’-(6-p-methoxyphenyl-1,3,5-triazine-2, 4-diyl)diphenol | 10 per cent | — | — |
| 26 | α-(Trimethylsilyl)-w-(trimethylsilyloxy)poly-[oxy(dimethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl]phenoxy]-1-methyleneethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl)]phenoxy]prop-1-enyl)silylene] where there are usually 60 polymeric units, of which the first part of the copolymer provides 56 (Dimethicodiethylbenzyalmalonate) (CAS No. 207574-74-1) | 10 per cent | — | — |
| 27 | Titanium dioxide | 25 per cent | — | — |
Commencement Information
I39Sch. 7 Pt. II in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I40Sch. 7 Pt. II in force at 11.3.2005 in so far as commenced by inducing reg. 7(2)(9), see reg. 1(2)
| (1) | (2) | (3) | (4) | (5) | (6) |
|---|---|---|---|---|---|
| Reference Number | Name of substance | Maximum concentration of substance in product | Other requirements | Required information | UV filter supplied until |
| Note: There are no entries in this Part at the date that these Regulations are made. | |||||
Regulation 5(5)
Commencement Information
I41Sch. 8 in force at 11.9.2004, see reg. 1(1)
The following are the methods of manufacture referred to in regulation 5(5)—
(a)transesterification or hydrolysis at a temperature of at least 200ºC and at an appropriate corresponding pressure for 20 minutes (glycerol, fatty acids and fatty acid esters);
(b)saponification with sodium hydroxide solution, c(NaOH) = 12mol/l (glycerol and soap)—
(i)batch process: at 95°C for three hours; or
(ii)continuous process: at 140°C, two bars (2,000hPa) for eight minutes, or equivalent conditions.
Regulations 7(2), 7(6) and 7(11)
Commencement Information
I42Sch. 9 Pt. 1 in force at 11.9.2004 as commenced by inducing reg. 7(6)(11) , see reg. 1(1)
Prospective
Commencement Information
I43Sch. 9 Pt. 2 in force at 11.3.2005 as commenced by reg. 7(2), see reg. 1(2)
Regulation 12(3) and (5)
1. The name or trade name and address or registered office of the applicant.U.K.
Commencement Information
I44Sch. 10 Pt. 1 para. 1 in force at 11.9.2004, see reg. 1(1)
2. Precise identification of the cosmetic ingredient for which confidentiality is requested, namely—U.K.
(a)where they exist, the CAS, EINECS and colour index numbers, the chemical name, the IUPAC name, the INCI name, the European Pharmacopoeia name, the International Non-proprietary Name as recommended by the World Health Organization and the common name as provided for in the common ingredients nomenclature;
(b)the European List of Notified Chemical Substances (ELINCS) name and the official number allocated to it if it has been notified pursuant to Council Directive 67/548/EEC(26) and an indication of the decision to approve or refuse any request for confidentiality made under Article 19 of that Directive;
(c)where the names or numbers referred to in sub-paragraphs (a) and (b) above do not exist, for example in the case of certain ingredients of natural origin, the name of the base material, the name of the part of the plant or animal used and the names of the cosmetic ingredient’s compounds, such as solvents.
Commencement Information
I45Sch. 10 Pt. 1 para. 2 in force at 11.9.2004, see reg. 1(1)
3. The evaluation of the safety for human health of the cosmetic ingredient as used in the finished cosmetic product or products taking into account the cosmetic ingredient’s toxicological profile, chemical structure and the level of exposure as specified in regulation 9(1)(d)and (e) and carried out in accordance with the requirements of regulations 9(2), 9(3) and 9(4).U.K.
Commencement Information
I46Sch. 10 para. 3 in force at 11.9.2004, see reg. 1(1)
4. The envisaged use of the cosmetic ingredient and in particular the different categories of cosmetic products in which it will be used.U.K.
Commencement Information
I47Sch. 10 para. 4 in force at 11.9.2004, see reg. 1(1)
5. A detailed justification of why confidentiality is sought addressing for example—U.K.
(a)the fact that the identify of the cosmetic ingredient or its function in the cosmetic product to be supplied has not been described in the literature accompanying the cosmetic product and is unknown to other manufacturers or suppliers of cosmetic products;
(b)the fact that the information is not yet in the public domain even though a patent application has been lodged for the cosmetic ingredient or its use;
(c)the fact that if the information were known it would be easily reproducible, to the detriment of the applicant.
Commencement Information
I48Sch. 10 para. 5 in force at 11.9.2004, see reg. 1(1)
6.—(1) If known, the name of each cosmetic product which is to contain the cosmetic ingredient and if different names are to be used in other Member States, precise details of each one of them.U.K.
(2) If the name of a cosmetic product is not yet known, it may be communicated at a later date, but at least 15 days before the cosmetic product is supplied.
(3) If the cosmetic ingredient is used in several products, one request shall suffice, provided that the cosmetic products are clearly indicated to the competent authority.
Commencement Information
I49Sch. 10 para. 6 in force at 11.9.2004, see reg. 1(1)
7. A statement setting out whether a request has been submitted to the competent authority of any other Member State in respect of the cosmetic ingredient for which confidentiality is sought and particulars on the outcome of any such request.U.K.
Commencement Information
I50Sch. 10 para. 7 in force at 11.9.2004, see reg. 1(1)
1. The registration number referred to in regulation 12(5) shall consist of seven digits, the first two corresponding to the year of approval of confidentiality, the second two to the code assigned to each Member State, as referred to in paragraph 2 below, and the final three digits assigned by the competent authority.U.K.
Commencement Information
I51Sch. 10 Pt. II para. 1 in force at 11.9.2004, see reg. 1(1)
2. The code allocated to the United Kingdom is 06.U.K.
Commencement Information
I52Sch. 10 Pt. II para. 2 in force at 11.9.2004, see reg. 1(1)
Regulation 17
1. In this Schedule—U.K.
“Annex A” means the Annex to Commission Directive No. 80/1335/EEC(27) as amended by Commission Directive No.87/143/EEC(28)
“Annex B” means the Annex to Commission Directive No. 82/434/EEC(29) as amended by Commission Directive No.90/207/EEC(30)
“Annex C” means the Annex to Commission Directive No. 83/514/EEC(31);
“Annex D” means the Annex to Commission Directive No. 85/490/EEC(32);
“Annex E” means the Annex to Commission Directive No. 93/73/EEC(33);
“Annex F” means the Annex to Commission Directive No. 95/32/EC(34);
“Annex G” means the Annex to Commission Directive No. 96/45/EC(35);
“purchase” means purchase for the purpose of carrying out a test.
Commencement Information
I53Sch. 11 para. 1 in force at 11.9.2004, see reg. 1(1)
2. An enforcement authority intending to purchase a cosmetic product shall purchase a sufficient laboratory sample, as defined in paragraph 2.3 of Part 1 of Annex A, for the purpose of Annex A; and, for the purposes of the definition of “total sample” in paragraph 2.2 of Part 1 of Annex A; samples shall be regarded as having the sample batch number if—U.K.
(a)the means of identifying the batch referred to in regulation 7(2)(h) above shows that they were manufactured in the same batch;
(b)in the case of a product not manufactured in a batch, the reference referred to in regulation 7(2)(h) above shows that they are derived from the same unit of production; or
(c)in the case of a product which does not comply with the requirements of regulation 7(2)(h) above, the officer effecting the purchase has reasonable cause to believe that they were manufactured in the same batch or are derived from the same unit of production, as the case may be.
Commencement Information
I54Sch. 11 para. 2 in force at 11.9.2004, see reg. 1(1)
3. The immediate container, if any, of a cosmetic product purchased by an enforcement authority shall not have been opened by, on behalf of or at the request of the enforcement authority before the purchase takes place and the container shall not thereafter be opened except in accordance with paragraph 5.3 of Part I of Annex A and paragraph 1.2 of Part II of Annex A.U.K.
Commencement Information
I55Sch. 11 para. 3 in force at 11.9.2004, see reg. 1(1)
4. As soon as an enforcement authority has purchased a cosmetic product, the officer effecting the purchase shall—U.K.
(a)either—
(i)place a seal on the product’s container or outer packaging; or
(ii)place the product in a container and forthwith place a seal on that container, in such a way that the product’s immediate container cannot be opened or (in the case of a product which was not in a container when it was purchased) the product cannot be touched without (in either case) the seal being broken in such a manner that it would be apparent thereafter that it had been broken, and
(b)attach to the product a label indicating—
(i)the name of the product,
(ii)the date, time and place at which the product was purchased,
(iii)his own name, and
(iv)the name of the enforcement authority making the purchase.
Commencement Information
I56Sch. 11 para. 4 in force at 11.9.2004, see reg. 1(1)
5.—(1) Subject to sub-paragraph (2) below, the provisions of Part 1 of Annex A, other than paragraphs 3.1, 3.2 and 4, and of Part II of Annex A, other than paragraph 1.4, shall be complied with in the sampling of cosmetic products and the laboratory preparation of test portions.U.K.
(2) Where, because of the way in which a cosmetic product is put up for sale, it is not practicable for Part II of Annex A to be complied with, it shall be prepared for testing in accordance with good analytical practice, and the person so preparing it shall record in writing the method of preparation which he has used.
Commencement Information
I57Sch. 11 para. 5 in force at 11.9.2004, see reg. 1(1)
6.—(1) Any test to determine whether a cosmetic product contains a significant amount of free sodium hydroxide or free potassium hydroxide shall be carried out in accordance with paragraphs 1 to 4 of Part III of Annex A.U.K.
(2) Any test to determine the amount of free sodium hydroxide or free potassium hydroxide in a hair straightener product or a nail cuticle solvent product shall be carried out in accordance with paragraphs 1, 2, 3 and 5 of Part III of Annex A.
(3) Any test to determine whether a hair-care product contains oxalic acid or any alkaline salt of oxalic acid or to determine the amount of such a substance in a hair-care product shall, subject to the limitation specified in the second sentence of paragraph 1 of Part IV of Annex A, be carried out in accordance with the said Part IV.
(4) Any test to determine the amount of chloroform in toothpaste shall, subject to the limitation specified in the second sentence of paragraph 1 of Part V of Annex A, be carried out in accordance with the said Part V.
(5) Any test to determine the amount of zinc chloride, zinc sulphate or zinc 4-hydroxybenzene- sulphonate by virtue of their zinc contents in a cosmetic product shall be carried out in accordance with Part VI of Annex A and Commission Directive 87/143/EEC(36), and shall take into account paragraph 11 of Part VII of Annex A.
(6) Any test to determine whether a cosmetic product contained in an aerosol dispenser or a cream, emulsion, lotion, gel or oil intended to be applied to the skin contains 4-hydroxybenzene-sulphonic acid, or to determine the amount of that acid in such a product, shall be carried out in accordance with Part VII of Annex A.
(7) Any test to determine whether a hair-care product contains persulphate, bromate or hydrogen peroxide shall be carried out in accordance with Part A of Part I of Annex B.
(8) Any test to determine whether a hair-care product contains barium peroxide shall be carried out in accordance with Part B of Part 1 of Annex B.
(9) Any test to determine the amount of hydrogen peroxide in a hair-care product shall be carried out in accordance with Part C of Part I of Annex B.
(10) Any test to determine whether a hair dye contains any of the oxidation colourants specified in paragraph 1 of Part II of Annex B, or to determine the amount of such a substance in a hair-dye, shall be carried out in accordance with the said Part II.
(11) Any test to determine whether a cosmetic product contains nitrite, or to determine the amount of that substance in a cosmetic product, shall be carried out in accordance with Part III of Annex B.
(12) Any test to determine whether a cosmetic product contains free formaldehyde, or to determine the amount of that substance in a cosmetic product, shall be carried out in accordance with Part IV of Annex B.
(13) Any test to determine the amount of resorcinol in a shampoo or hair lotion shall, subject to the limitation specified in the second sentence of paragraph 1 of Part V of Annex B, be carried out in accordance with the said Part V.
(14) Any test to determine the amount of methanol in relation to ethanol or propan-2-ol in a cosmetic product shall be carried out in accordance with Part VI of Annex B.
(15) Any test to determine the amount of dichloromethane or 1,1,1-trichloroethane in a cosmetic product shall be carried out in accordance with paragraphs 1 to 10 of that part of Annex C which is headed “Determination of dichloromethane and 1,1,1-trichloroethane”.
(16) Any test to determine whether a cosmetic product contains quinolin-8-ol or bis(8-hydroxyquinolinium) sulphate, or to determine the amount of such a substance in a cosmetic product, shall be carried out in accordance with paragraphs 1 to 9 of that part of Annex C which is headed “Identification and determination of quinolin-8-ol-and bis(8-hydroxyquinolinium) sulphate”.
(17) Any test to determine the amount of ammonia in a cosmetic product shall be carried out in accordance with paragraphs 1 to 8 of that part of Annex C which is headed “Determination of ammonia”.
(18) Any test to determine whether a cosmetic product contains nitromethane, or to determine the amount of that substance in a cosmetic product, shall be carried out in accordance with paragraphs 1 to 7 of that part of Annex C which is headed “Identification and determination of nitromethane”.
(19) Any test to determine whether a hair waving, hair straightening or depilatory product contains mercaptoacetic acid (thioglycolic acid), or to determine the amount of that substance in such a product, shall be carried out in accordance with paragraphs 1 to 6 of that part of Annex C which is headed “Identification and determination of mercaptoacetic acid in hair waving, hair straightening and depilatory products”.
(20) Any test to determine whether a cosmetic product contains hexachlorophene (INN) shall be carried out in accordance with paragraphs 1 to 7 of Part A of that part of Annex C which is headed “Identification and determination of hexachlorophene”.
(21) Any test to determine the amount of hexachlorophene (INN) in a cosmetic product shall be carried out in accordance with paragraphs 1 to 9 of Part B of that part of Annex C which is headed “Identification and determination of hexachlorophene”.
(22) Any test to determine the amount of tosylchloramide sodium (INN) in a cosmetic product shall be carried out in accordance with paragraphs 1 to 9 of that part of Annex C which is headed “Quantitative determination of tosylchloramide sodium (INN) (chloramine-T)”.
(23) Any test to determine the total amount of fluorine in dental creams shall be carried out in accordance with paragraphs 1 to 8 of that part of Annex C which is headed “Determination of total fluorine in dental creams”.
(24) Any test to determine whether a cosmetic product contains organomercury compounds shall be carried out in accordance with paragraphs 1 to 4 of Part A of that part of Annex C which is headed “Identification and determination of organomercury compounds”.
(25) Any test to determine the amount of organomercury compounds in a cosmetic product shall be carried out in accordance with paragraphs 1 to 7 of Part B of that part of Annex C which is headed “Identification and determination of organomercury compounds”.
(26) Any test to determine the amount of alkali sulphides or alkaline earth sulphides in a cosmetic product shall be carried out in accordance with paragraphs 1 to 8 of that part of Annex C which is headed “Determination of alkali and alkaline earth sulphides”.
(27) Any test for the identification and determination of the amount of glycerol 1-(4-aminobenzoate) in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of glycerol 1-(4-aminobenzoate)”.
(28) Any test to determine the amount of chlorobutanol (INN) in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Determination of chlorobutanol”.
(29) Any test for the identification and determination of the amount of quinine in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of quinine”.
(30) Any test for the identification and determination of inorganic sulphites and hydrogen sulphites in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of inorganic sulphites and hydrogen sulphites”.
(31) Any test for the identification and determination of chlorates of the alkali metals in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of chlorates of the alkali metals”.
(32) Any test for the identification and determination of sodium iodate in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of sodium iodate”.
(33) Any test for the identification and determination of silver nitrate in a cosmetic product shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of silver nitrate in cosmetic products”.
(34) Any test for the identification and determination of selenium disulphide in anti-dandruff shampoos shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of selenium disulphide in anti-dandruff shampoos”.
(35) Any test for the determination of soluble barium and soluble strontium in pigments in the form of salts or lakes shall be carried out in accordance with that part of Annex E which is headed “Determination of soluble barium and strontium in pigments in the form of salts or lakes”.
(36) Any test for the identification and determination of benzyl alcohol in a cosmetic product shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of benzyl alcohol in cosmetic products”.
(37) Any test for the identification of zirconium and the determination of zirconium, aluminium and chlorine in non-aerosol anti-perspirants shall be carried out in accordance with that part of Annex E which is headed “identification of zirconium, and determination of zirconium, aluminium and chlorine in non-aerosol anti-perspirants”.
(38) Any test for the identification and determination of hexamidine, dibromohexamidine, dibromopropamidine and chlorhexidine in a cosmetic product shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of hexamidine, dibromohexamidine, dibromopropamidine and chlorhexidine”.
(39) Any test for the identification and determination of benzoic acid, 4-hydroxybenzoic acid, sorbic acid, salicylic acid and propionic acid in a cosmetic product shall be carried out in accordance with that part of Annex F which is headed “Identification and determination of benzoic acid, 4-hydroxybenzoic acid, sorbic acid, salicylic acid and propionic acid in cosmetic products”.
(40) Any test for the identification and determination of hydroquinone, hydroquinone monomethyl ether, hydroquinone monoethyl ether and hydroquinone monobenzyl ether (monobenzone) in a cosmetic product shall be carried out in accordance with that part of Annex F which is headed “Identification and determination of hydroquinone, hydroquinone monomethyl ether, hydroquinone monoethyl ether and hydroquinone monobenzyl ether in cosmetic products”.
(41) Any test for the identification and determination of 2-phenoxyethanol, 1-phenoxypropan-2-ol, and methyl, ethyl, propyl, butyl and benzyl 4-hydroxybenzoate in a cosmetic product shall be carried out in accordance with Annex G.
Commencement Information
I58Sch. 11 para. 6 in force at 11.9.2004, see reg. 1(1)
Regulation 3(1), 5(7), (9) and (12)
Commencement Information
I59Sch. 12 Pt. 1 in force at 11.9.2004, see reg. 1(1)
Part 1 of this Schedule lists the alternative methods validated by the European Centre for the Validation of Alternative Methods (“ECVAM”) which are necessary to meet the requirements of these Regulations and which are listed in Annex V to Council Directive 67/548/EEC of 27th June 1967 on the approximation of laws, regulations and administrative provisions relating to classification, packaging and labelling of dangerous substances (37).
The reference number given in the second column of the table in Part 1 refers to the reference number under which the type of test is listed in Annex V to Directive 67/548/EEC.
| Entry Number | Reference Number | Type of Test (toxicological endpoint) | Alternative Test Method | Date after which this method is required to be used |
|---|---|---|---|---|
| 1 | B40 | Skin corrosion | Rat skin TER assay | 11.9.04 |
| 2 | B40 | Skin corrosion | Human skin model assay | 11.9.04 |
| 3 | B41 | Phototoxicity | In vitro 3T3 NRU phototoxicity test | 11.9.04 |
Commencement Information
I60Sch. 12 Pt. 2 in force at 11.9.2004, see reg. 1(1)
Part 2 of this Schedule lists the alternative methods validated by ECVAM which are necessary to meet the requirements of these Regulations and which are listed in Annex IX to the Directive. As an alternative method may not replace completely the experimentation on animals, column 3 of the table below specifies whether the alternative method fully or partially replaces the animal test.
| Entry Number | Reference Number | Nature of replacement | Alternative Test Method | Date after which this method is required to be used |
|---|---|---|---|---|
| Note: There are no entries in this Part at the date that these Regulations are made. | ||||
Regulation 5(15)
Commencement Information
I61Sch. 13 in force at 11.9.2004, see reg. 1(1)
The substances listed in this table are classified as carcinogenic, mutagenic or toxic for reproduction under directive 67/548/EEC(38) and in the approved supply list. These substances have been evaluated as safe by the Scientific Committee on Cosmetic Products(39) in accordance with article 4b of the Directive and are permitted for use in cosmetic products.
| Substance | Index Number | EC Number | CAS Number |
|---|---|---|---|
| Note: There are no entries in this Part at the date that these Regulations are made. | |||
(This note is not part of the Order)
These Regulations revoke and re-enact the Cosmetic Products (Safety) Regulations 2003 (S.I. 2003/835) (“the 2003 Regulations”). The 2003 Regulations give effect to Council Directive 76/768/EEC (O.J. No. L262, 27.9.76, p.169) (“the Directive”) on the approximation of the laws of the Member States relating to cosmetic products, as amended by the Community instruments listed in Schedule 2 to these Regulations.
These Regulations also give effect for the first time to Council Directive 2003/15/EC (O.J. L66, 11.3.2003, p.26) which amends Directive 67/548/EEC for the 7th time, as follows:
(a)Prohibit the supply of cosmetic products where the final formulation or ingredients have been tested on animals using a method other than an “alternative method”. The Regulations also introduce an outright prohibition in respect of the supply of cosmetic products after specified dates (2009 and 2013);
(b)Prohibit the testing of “finished cosmetic products” on animals with immediate effect;
(c)Prohibit the testing of ingredients for use in cosmetic products after specified dates;
(d)Introduce provisions governing the use by cosmetic product manufacturers of claims in respect of animal testing;
(e)Prohibit the use in cosmetic products of substances which are classified under directive 67/548/EEC as carcinogenic, mutagenic or toxic to reproduction (and listed in the approved supply list) subject to an exemption in respect of substances which have been evaluated as safe by the Scientific Committee on Cosmetic Products(40);
(f)Requires manufacturers to label products with a symbol (contained in Schedule 9, Part 2) indicating the time after opening after which the product may harm the consumer (this only applies to products with a minimum durability of more than 30 months);
(g)Requires certain perfumes and aromatic compositions to be specifically listed on product packaging;
(h)Requires a specific safety assessment to be undertaken in respect of cosmetic products intended for children or for intimate hygiene;
(i)Inserts further entries into Schedule 4 to these Regulations;
These Regulations also give effect to Council Directive 2003/80/EC (O.J. No. 224, 6.9.2003, p.27) which amends the Directive for the 30th time. Directive 2003/80/EC amends the Directive by inserting a new Annex VIIIa containing a symbol to be used by manufacturers to indicate the time after opening after which the product may harm the consumer (as required by Directive 2003/15/EC).
These Regulations also give effect to Council Directive 2003/83 (O.J. No. L238, 25.9.2003, p.23) which amends the Directive by inserting, deleting or amending entries in Annexes II, III and VI. These Regulations make appropriate amendments to Schedules 3,4 and 6, which implement those Annexes. Directive 2003/83/EC requires Member States to ensure that cosmetic products, which fail to comply with that directive, shall not be placed on the market from 24th March 2005 and that they shall not be supplied to the final consumer from 24th September 2005. Accordingly, regulations 1(3) and 1(4) provide that newly inserted or amended entries in the schedules to the regulations shall not have effect until 24th March 2005. Equally, these regulations provide that certain entries, which are amended or deleted by 2003/83, shall continue to operate in their existing form (i.e. as they appear in the Cosmetic Products (Safety) Regulations 2003) until 24th March 2005. Regulation 16(3) provides that no proceedings or enforcement action shall be taken in respect of the new or amended entries where the cosmetic product in question is placed on the market before 24th March 2005 and is supplied before 24th September 2005.
The Colour Index referred to in these Regulations may be obtained from the Society of Dyers and Colourists and the American Society of Textile Chemists and Colourists by on-line subscription at http://www.colour-index.org/.
A full regulatory impact assessment of the effect that this instrument will have on costs to business is available from the Consumer and Competition Policy Directorate of the Department of Trade and Industry, 1 Victoria Street, London SW1H 0ET. Copies of a transposition note relating to these Regulations have been placed in the libraries of both Houses of Parliament. Copies are also available to the public from the Consumer and Competition Policy Directorate of the Department of Trade and Industry, 1 Victoria Street, London SW1H 0ET.
O.J. No. L132, 1.6.96, p.1.
O.J. No L140, 23.6.95, p. 26.
O.J. No. L262, 27.9.76, p. 169.
O.J No. L147, 31.5.01, p.1.
An ingredient’s CTFA name is the name given to it by the Cosmetics, Toiletries and Fragrances Association (CTFA) and listed in the tenth edition of the International Cosmetic Ingredient Dictionary and Handbook (ISBN 1-882621-34-4) published in 2004 by The Cosmetic Toiletry and Fragrance Association. Its EINECS identification reference is the reference given in the European Inventory of Existing Commercial Chemical Substances. Its IUPAC identification reference is the reference given by the International Union of Pure and Applied Chemistry. Its CAS identification reference is the reference assigned by the Chemical Abstracts Service. An ingredient’s colour index number is the number specified in the fourth edition of The Colour Index published by the Society of Dyers and Colourists and the American Society of Textile Chemists and Colourists (available by on-line subscription at http://www.colour-index.org/). European Pharmacopoeia names, International Non-proprietary Names and EINECS, IUPAC and CAS identification references are listed in Commission Decision 96/335/EC (O.J.No. L132, 1.6.96, p.1.).
O.J. No. L50, 20.2.2004, p. 44, implemented by the Good Laboratory Practice (Codification Amendment Etc.) Regulations (S.I. 2004/994).
S.I. 1991/824, to which there is an amendment not relevant to these Regulations.
SI 2003/835 revoked by these regulations
O.J. No. L132, 1.6.1996, p.1.
Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as a percentage of sodium hydroxide. In cases of mixtures, the sun must not exceed the limits given in column 4.
O.J. No. 115, 11.11.62, p.2645.
Council Directives Nos. 65/469/EEC, 67/653/EEC, 68/419/EEC, 70/358/EEC, 76/399/EEC, 78/144/EEC, 81/20/EEC and
85/7/EEC (O.J. Nos. L178, 26.10.65, p.2793; L263, 30.10.67, p. 4; L309, 24.12.68, p.24; L157, 18.7.70, p.36; L108,26.4.76, p.19; L44, 15.2.78, p.20; L43, 14.2.81, p.11; L2, 3.1.85, p.22).
Annexes 1 and VII to the Act of Accession of 22nd January 1972, as adjusted by the Council Decision of 1st January 1973 (O.J. No. L2, 1.1.73, p.1).
Council Directive 94/36/EC (O.J) No. L237, 10.9.94, p.13) and Commission Directive 95/45/EC (O.J. No. L226, 22.9.95, p.1).
O. J. No. L132, 1.6..96, p.1.
O.J. No. L132, 1.6.96, p.1.
O.J. l 196, 16.8.1967, p.1 as last amended by Directive 2004/73/EEC (O.J. L152, 30.4.2004, p.1)
O.J. No. L383, 31.12.80, p.27.
O,J. No. L57, 27.2.87, p.56.
O.J. No. L185, 30.6.82, p.1.
O.J. No. L108, 28.4.90, p.92.
O.J. No. L291, 24.10.83, p.9.
O.J. No. L295, 7.11.85, p.30.
O.J. No. L231, 14.9.93, p.34.
O.J. No.L178, 28.7.95, p.20.
O.J. No. L213, 2.7.96, p.8.
O.J. No. L57, 27.2.87, p.56.
O.J. l 196, 16.8.1967, p.1 as last amended by Directive 2004/73/EC (O.J. L152, 30.4.2004, p.1)
Council Directive 1967/548/EEC (OJ 196,16.8.67, p.1) as last amended by 2004/73/EC (O.J. L152, 30.4.2004, p.1)
the Scientific Committee on Cosmetic Products was previously called the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (“SCCNFP”)
the Scientific Committee on Cosmetic Products was previously called the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (“SCCNFP”)